WO2006101237A1 - Freeze storage container and process for producing the same - Google Patents
Freeze storage container and process for producing the same Download PDFInfo
- Publication number
- WO2006101237A1 WO2006101237A1 PCT/JP2006/306183 JP2006306183W WO2006101237A1 WO 2006101237 A1 WO2006101237 A1 WO 2006101237A1 JP 2006306183 W JP2006306183 W JP 2006306183W WO 2006101237 A1 WO2006101237 A1 WO 2006101237A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluorine
- group
- adhesive
- film
- containing polymer
- Prior art date
Links
- 238000003860 storage Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title description 46
- 230000008569 process Effects 0.000 title description 9
- 230000001070 adhesive effect Effects 0.000 claims abstract description 163
- 239000000853 adhesive Substances 0.000 claims abstract description 162
- 229910052731 fluorine Inorganic materials 0.000 claims description 188
- 239000011737 fluorine Substances 0.000 claims description 172
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 164
- 239000000178 monomer Substances 0.000 claims description 97
- 238000005138 cryopreservation Methods 0.000 claims description 90
- 229920006254 polymer film Polymers 0.000 claims description 61
- 229920005989 resin Polymers 0.000 claims description 44
- 239000011347 resin Substances 0.000 claims description 44
- 125000004432 carbon atom Chemical group C* 0.000 claims description 43
- 229920001721 polyimide Polymers 0.000 claims description 42
- 229920001577 copolymer Polymers 0.000 claims description 39
- 239000004642 Polyimide Substances 0.000 claims description 38
- -1 perfluoro (vinylmethyl) Chemical group 0.000 claims description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 125000000524 functional group Chemical group 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 24
- 125000001153 fluoro group Chemical group F* 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 125000002947 alkylene group Chemical group 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 16
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 239000005977 Ethylene Substances 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical group FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000003700 epoxy group Chemical group 0.000 claims description 9
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 9
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 7
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 claims description 6
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 claims description 6
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 5
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 5
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 5
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 5
- CJENPNUXCMYXPT-UHFFFAOYSA-N 1-chloro-1,2-difluoroethene Chemical group FC=C(F)Cl CJENPNUXCMYXPT-UHFFFAOYSA-N 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 45
- 239000007788 liquid Substances 0.000 abstract description 24
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 22
- 229920002313 fluoropolymer Polymers 0.000 abstract description 16
- 239000004811 fluoropolymer Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 6
- 241000700605 Viruses Species 0.000 abstract description 6
- 238000011109 contamination Methods 0.000 abstract description 6
- 238000010257 thawing Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 19
- 239000012472 biological sample Substances 0.000 description 17
- 238000001125 extrusion Methods 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 238000007334 copolymerization reaction Methods 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- 238000006116 polymerization reaction Methods 0.000 description 13
- 238000000465 moulding Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 238000003475 lamination Methods 0.000 description 9
- 125000005587 carbonate group Chemical group 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 239000011368 organic material Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 238000010030 laminating Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000012503 blood component Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000001772 blood platelet Anatomy 0.000 description 4
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000000748 compression moulding Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 239000011229 interlayer Substances 0.000 description 4
- 229920005604 random copolymer Polymers 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000002788 crimping Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 238000003898 horticulture Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 238000000807 solvent casting Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000009823 thermal lamination Methods 0.000 description 3
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- AYKYXWQEBUNJCN-UHFFFAOYSA-N 3-methylfuran-2,5-dione Chemical compound CC1=CC(=O)OC1=O AYKYXWQEBUNJCN-UHFFFAOYSA-N 0.000 description 2
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- UUAGAQFQZIEFAH-UHFFFAOYSA-N chlorotrifluoroethylene Chemical compound FC(F)=C(F)Cl UUAGAQFQZIEFAH-UHFFFAOYSA-N 0.000 description 2
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 2
- 229940018557 citraconic acid Drugs 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010292 electrical insulation Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000005001 laminate film Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 2
- 239000002120 nanofilm Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KDGNCLDCOVTOCS-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy propan-2-yl carbonate Chemical compound CC(C)OC(=O)OOC(C)(C)C KDGNCLDCOVTOCS-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- LFKIWESNALQTIC-UHFFFAOYSA-N 1,1,2,2,3,3-hexafluoro-3-(1,2,2-trifluoroethenoxy)propan-1-ol Chemical compound OC(F)(F)C(F)(F)C(F)(F)OC(F)=C(F)F LFKIWESNALQTIC-UHFFFAOYSA-N 0.000 description 1
- MIZLGWKEZAPEFJ-UHFFFAOYSA-N 1,1,2-trifluoroethene Chemical group FC=C(F)F MIZLGWKEZAPEFJ-UHFFFAOYSA-N 0.000 description 1
- FRCHKSNAZZFGCA-UHFFFAOYSA-N 1,1-dichloro-1-fluoroethane Chemical compound CC(F)(Cl)Cl FRCHKSNAZZFGCA-UHFFFAOYSA-N 0.000 description 1
- BEQKKZICTDFVMG-UHFFFAOYSA-N 1,2,3,4,6-pentaoxepane-5,7-dione Chemical compound O=C1OOOOC(=O)O1 BEQKKZICTDFVMG-UHFFFAOYSA-N 0.000 description 1
- SOZFIIXUNAKEJP-UHFFFAOYSA-N 1,2,3,4-tetrafluorobenzene Chemical compound FC1=CC=C(F)C(F)=C1F SOZFIIXUNAKEJP-UHFFFAOYSA-N 0.000 description 1
- APQOMSCEPGHMDB-UHFFFAOYSA-N 2,2,3,3-tetrafluoro-3-(1,2,2-trifluoroethenoxy)propanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)OC(F)=C(F)F APQOMSCEPGHMDB-UHFFFAOYSA-N 0.000 description 1
- SJGGAMMXIZFWSF-UHFFFAOYSA-N 2,3,3-trifluoroprop-2-enoyl fluoride Chemical compound FC(F)=C(F)C(F)=O SJGGAMMXIZFWSF-UHFFFAOYSA-N 0.000 description 1
- DIOZVWSHACHNRT-UHFFFAOYSA-N 2-(2-prop-2-enoxyethoxy)ethanol Chemical compound OCCOCCOCC=C DIOZVWSHACHNRT-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- WOLRBLILVRYDQP-UHFFFAOYSA-N 2-(trifluoromethyl)prop-2-enoyl fluoride Chemical compound FC(=O)C(=C)C(F)(F)F WOLRBLILVRYDQP-UHFFFAOYSA-N 0.000 description 1
- GYIYNNBYDCPYEG-UHFFFAOYSA-N 2-carboxyoxycarbonyloxyacetic acid Chemical compound OC(=O)COC(=O)OC(O)=O GYIYNNBYDCPYEG-UHFFFAOYSA-N 0.000 description 1
- LWCDSJZGNUDNCO-UHFFFAOYSA-N 2-fluorobut-2-enoic acid Chemical compound CC=C(F)C(O)=O LWCDSJZGNUDNCO-UHFFFAOYSA-N 0.000 description 1
- TYCFGHUTYSLISP-UHFFFAOYSA-N 2-fluoroprop-2-enoic acid Chemical compound OC(=O)C(F)=C TYCFGHUTYSLISP-UHFFFAOYSA-N 0.000 description 1
- QMIWYOZFFSLIAK-UHFFFAOYSA-N 3,3,3-trifluoro-2-(trifluoromethyl)prop-1-ene Chemical compound FC(F)(F)C(=C)C(F)(F)F QMIWYOZFFSLIAK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 108700042768 University of Wisconsin-lactobionate solution Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 125000004018 acid anhydride group Chemical group 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 125000003355 oxamoyl group Chemical group C(C(=O)N)(=O)* 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 229920009441 perflouroethylene propylene Polymers 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- HJBYJZCUFFYSGA-UHFFFAOYSA-N prop-2-enoyl fluoride Chemical compound FC(=O)C=C HJBYJZCUFFYSGA-UHFFFAOYSA-N 0.000 description 1
- RGBXDEHYFWDBKD-UHFFFAOYSA-N propan-2-yl propan-2-yloxy carbonate Chemical compound CC(C)OOC(=O)OC(C)C RGBXDEHYFWDBKD-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- YPVDWEHVCUBACK-UHFFFAOYSA-N propoxycarbonyloxy propyl carbonate Chemical compound CCCOC(=O)OOC(=O)OCCC YPVDWEHVCUBACK-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- XTVMZZBLCLWBPM-UHFFFAOYSA-N tert-butylcyclohexane Chemical compound CC(C)(C)C1CCCCC1 XTVMZZBLCLWBPM-UHFFFAOYSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229920006259 thermoplastic polyimide Polymers 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
- A01N1/147—Carriers for immersion in cryogenic fluid for slow freezing or vitrification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0096—Casings for storing test samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/42—Low-temperature sample treatment, e.g. cryofixation
Definitions
- the present invention relates to a cryopreservation container and a method for producing the same.
- a cryopreservation container comprising at least an adhesive fluorine-containing polymer film, preferably a laminate film including at least an adhesive fluorine-containing polymer film and a cold-resistant resin film, the laminate film.
- the invention relates to a cryopreservation container in which at least one surface of the film is an adhesive fluorine-containing polymer film.
- blood, rare cells, living tissues, and the like are stored at a cryogenic temperature of about 80 to 196 ° C.
- rare cells such as bone marrow cells and hematopoietic stem cells are effective in treating intractable diseases such as leukemia, and long-term storage techniques are required.
- cryopreservation containers used for storage for example, polypropylene-made needles are commercially available at the laboratory level, and are inexpensive and easy to handle.
- Patent Document 1 discloses a film having a laminated film strength of a polyimide film and a fluorinated ethylene propylene polymer film (Patent Document 1), a film having a film power of a copolymer of tetrafluoroethylene and ethylene (Patent Document 2), etc.
- Patent Document 3 discloses a cryopreservation container formed of a film of an ethylene vinyl acetate copolymer that has been biaxially stretched by electron beam irradiation.
- Patent Document 4 discloses a cryopreservation container formed of a biaxially stretched crosslinked polyethylene film.
- the fluorocarbon resins disclosed in Patent Documents 1 and 2 are required to be manufactured by heat sealing at a high temperature with a high melting point. Despite being manufactured under the conditions, the seal strength is weak, so it often breaks during cryopreservation.
- the stretched film disclosed in Patent Documents 3 and 4 is heat sealed. The film shrinks and wrinkles in the seal area and its surroundings due to the operation, and in actual use, it may often be damaged by rough handling.
- the adhesive layer may harden during low-temperature storage, and the laminated film may peel off, making it suitable as a cryopreservation container. It is not a thing.
- ultrahigh molecular weight polyethylene is very excellent in that it is impact resistant, abrasion resistant, self-swelling, chemical resistant, cold resistant and non-toxic, but it is extremely high !, melt viscosity Therefore, the film production method is usually made by cutting a powdery raw material resin into a block-shaped product by compression molding or the like.
- the molding force is not easy.
- polyethylene on the surface of the film may fall off if there is a paste, and if used as a medical bag, it may cause contamination.
- compression molding air is taken in at the time of molding, and pinholes may occur in the film cut in the next process.
- the molecular weight of ultra-high molecular weight polyethylene is as high as 1 million or more, so the fluidity of polyethylene molecular chains is poor. Therefore, there is a problem in stable production of containers that are difficult to heat seal.
- Patent Document 1 Japanese Patent Publication No.49-008079
- Patent Document 2 Japanese Utility Model Publication No. 55-055069
- Patent Document 3 Japanese Patent Publication No. 55-044977
- Patent Document 4 Japanese Patent Publication No. 62-057351
- Patent Document 5 Japanese Patent Laid-Open No. 7-246230 Disclosure of the invention
- the present inventors propose to use an adhesive fluorine-containing polymer film for a cryopreservation container.
- Adhesive fluorine-containing polymer film is composed of a fluorine-containing polymer having an adhesive site
- the cryopreservation container according to [2] which is at least one selected from the group consisting of:
- the adhesive fluorine-containing polymer has a reactive functional group as an adhesive site, and is a copolymer obtained by copolymerizing the following (A) and (B): [3] Described cryopreservation container:
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Y is a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or a fluorine-containing alkyl group having 1 to 5 carbon atoms. Is a alkyl group
- a fluorine-containing monomer having a reactive functional group is represented by the following formula (2) [4] to [
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group
- R is a carbon number f.
- ⁇ 1 and ⁇ are each a hydrogen atom or a halogen atom
- ⁇ 1 and ⁇ 2 are a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a fluorine-containing group having 1 to 5 carbon atoms, respectively.
- ⁇ is a hydroxyl group, a carboxyl group, a cyano group
- R is a fluorine-containing alkylene group having 1 to 40 carbon atoms
- a fluorine-containing oxyalkylene group having 1 to 40 carbon atoms or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn force is 2000
- the adhesive fluorine-containing polymer has a fluorine-containing monomer unit derived from a fluorine-containing monomer and a fluorine-free monomer unit derived from a fluorine-free monomer.
- the cold-resistant resin is at least one selected from the group consisting of ultrahigh molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene acetate butyl copolymer
- a method for producing a cryopreservation container wherein at least an adhesive fluorine-containing polymer film is formed into a bag shape by heat sealing,
- a laminated film including at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, wherein the adhesive fluorine-containing polymer film is present on at least one outermost surface is heated.
- the present invention relates to the method for producing a cryopreservation container according to [15], which is formed into a bag shape with a seal.
- cryopreservation container of the present invention can be heat-sealed even at a low temperature, the container can be stably manufactured without manufacturing the noggles under severe conditions. In addition, because the heat seal strength is strong, it is possible to prevent the container from being damaged during cryopreservation. Precious biological samples can be stably stored.
- the cryopreservation container of the present invention includes at least an adhesive fluorine-containing polymer film.
- the adhesive fluorine-containing polymer film is a film formed of a polymer having at least one fluorine atom in the main chain and Z or side chain, and the film adheres to a substrate made of an organic material. It has a function.
- adheresion means that the above-mentioned adhesive fluorine-containing polymer film is bonded to the organic material by physical and Z or chemical bonding. From the viewpoint of bonding strength, chemical bonding is preferable. It is not limited to this. Examples of the chemical bond include a covalent bond, an ionic bond, a coordination bond, a hydrogen bond, and an intermolecular force. From the viewpoint of bond strength, the bond is preferably a covalent bond and an ionic bond, and more preferably a covalent bond. Is not limited to this force
- the organic material includes polyethylene, polycarbonate, polystyrene, and polyvinyl chloride.
- -Films made of cold-resistant resin such as rubber, polyacetate butyl, polyester and ultra high molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer and ethylene vinyl acetate copolymer, General purpose resin molding products such as tubes, synthetic fibers, synthetic rubbers and solid materials, and natural organic materials such as natural rubber, natural fibers, wood, papers and leathers. Includes the molecule itself. Among them, from the viewpoint of improving the cold resistance of the cryopreservation container itself, it is preferable that it can be adhered to an organic material having a function of adhering to the adhesive fluorine-containing polymer film itself and the cold resistant resin film. It is not limited to this.
- the molecular weight of the above-mentioned adhesive fluorine-containing polymer is about 1,000 to 1,000,000, preferably ⁇ is about 2,000 to 500,000 in terms of number average molecular weight. More preferred, ⁇ is a force that is about 5,000-300,000, but is not limited to this.
- the above-mentioned adhesive fluorine-containing polymer film can be produced by a person skilled in the art selecting a suitable production method in a timely manner according to the molecular structure of the adhesive fluorine-containing polymer, the glass transition temperature, the melting point, and the like.
- compression molding, injection molding, extrusion molding, ⁇ die molding, inflation Examples include sill molding and solvent casting, and compression molding is preferred from the viewpoint of molding processability, but is not limited thereto.
- the film thickness of the adhesive fluorine-containing polymer film is about 10 to: LOO / zm, preferably 10 to 50 ⁇ m, and particularly preferably 10 to 30 ⁇ m, from the viewpoint of thermal conductivity to the contents.
- the present invention is not limited to this.
- Preferred examples of the above-mentioned adhesive fluorine-containing polymer include a copolymer containing the following (A) and (B).
- the reactive functional group in the present invention is a functional group capable of adhering to the base material made of the organic material through a covalent bond, an ionic bond, a coordinate bond, a hydrogen bond, and the like.
- Examples thereof include a carboxyl group, a cyano group, a sulfonic acid group, and an epoxy group.
- a hydroxyl group that is easily activated by heat is preferable, but is not limited thereto.
- the fluorine-containing monomer is a monomer in which at least one hydrogen atom in the main chain and Z or side chain of the copolymer obtained by polymerization is substituted with fluorine.
- fluorine examples thereof include fluorine ethylenic monomers, fluorine-containing ester monomers, and fluorine-containing wholly aromatic monomers.
- a fluorine-containing ethylene monomer is preferable from the viewpoint of easy availability and molding moldability of the resulting copolymer, but is not limited thereto.
- the copolymer may be a two-component system obtained by polymerizing at least one of each of (A) and (B).
- a two-component system consisting of one (A) monomer and one (B) monomer a three-component system consisting of two (A) monomers and one (B) monomer
- Examples include a three-component system composed of one type of monomer (A) and two types of monomer (B).
- a two- or three-component system is preferable from the viewpoint of production cost, but is not limited thereto.
- Examples of the copolymer include radical copolymerization, anion copolymerization, cationic copolymerization, emulsion copolymerization, and plasma copolymerization. Depending on the monomer structure, polarity, type of solvent, etc. Those skilled in the art can select it in a timely manner. Of these, radical copolymerization is preferred from the viewpoint of ease of production! /, But is not limited to this! /.
- Examples of the form of the copolymer include a random copolymer, a block copolymer, a graft copolymer, and an alternating copolymer.
- random copolymer is preferred from the viewpoint of manufacturability, but it is not limited to this.
- the abundance ratio (copolymerization ratio) between (A) and (B) in the above copolymer is (1) from the viewpoint of the formation caloric property of the copolymer.
- A) is 1 to 2000, preferably 100 to 2000, but is not limited thereto.
- the (A) fluorine-containing monomer having no reactive functional group is a main chain and a Z or side chain of a copolymer that does not have the above-mentioned reactive functional group and is obtained by polymerization.
- a copolymer in which at least one hydrogen atom is substituted with fluorine is obtained.
- a fluorine-containing ethylenic monomer having no reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
- the (A) fluorine-containing ethylenic monomer having no reactive functional group contains at least one fluorine atom, and examples thereof include a monomer represented by the following formula (1).
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Y is a hydrogen atom, a fluorine atom, a fluorinated alkyl group having 1 to 5 carbon atoms or a fluorinated oxyalkyl group having 1 to 5 carbon atoms.
- Monomers represented by the above formula (1) include, for example, tetrafluoroethylene, vinylidene fluoride, 1,2-difunoleochloroethylene, hexafluororeopropylene, perfnoreo (bulurmethyl ether). ) And perfluoro (bulupropyl ether), preferably tetrafluoroethylene, vinylidene fluoride, 1,2-difluorochloroethylene and perfluoro (bulupropyl ether).
- perfluoro bulupropyl ether
- Tylene, vinylidene fluoride, hexafluoropropylene and perfluoro (bulupropyl ether) are preferred, but not limited thereto.
- the fluorine-containing monomer having at least one kind of reactive functional group has at least one reactive functional group described above, and the main chain of the copolymer obtained by polymerization and Z or A copolymer in which at least one hydrogen atom in the side chain is substituted with fluorine is obtained.
- a fluorine-containing ethylenic monomer having a reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group
- R is a carbon number f.
- Examples of the monomer represented by the above formula (2) include perfluoro- (4 oxa 5 monohexenol) (formula (4)), perfluoro (1, 1-dihydro-6 heptenol) (formula (5)), Perfluoro (1, 1, 9, 9—Tetrahydride 2,5 Bistrifluoromethyl-3, 6-Dioxer 8-Nenol) (Formula (6)), Perfluoro (4-Oxa-5-hexenoic acid) (Formula (7)), perfluoro- (3,6-dioxa-4-trifluoromethyl-7-otatheno-tolyl) (formula (8)), perfluoro- (1,1-dihydride 3 Ntenosulfonic acid) (formula (9)) and 1,2 epoxy-perfluoro- (1,1,2 trihydr draw 6 pentene) (formula (10)), and the like.
- a preferred form of the adhesive fluorine-containing polymer in the present invention is exemplified by a copolymer represented by the following formula (3) from the viewpoint of ease of production, but is not limited thereto. It is not something.
- X 1 and X 2 are each a hydrogen atom or a halogen atom, and ⁇ 1 and ⁇ 2 are each a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a carbon atom having 1 to 5 carbon atoms.
- a fluorine alkoxy group, z is a hydroxyl group, carboxyl group, cyano group, sulfonic acid group or epoxy group
- R is a fluorine-containing alkylene group having 1 to 40 carbon atoms, f
- x 1 and x 2 are hydrogen atoms or halogen atoms, respectively, and ⁇ 1 and ⁇ 2 are Respectively a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or 1 carbon atom
- R is carbon number 1
- f is a fluorine-containing alkylene group having 40 to 40 carbon atoms, a fluorine-containing alkylene group having 1 to 40 carbon atoms, or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn
- polytetrafluoropolymer is preferable from the viewpoint of easy availability of monomers, ease of production, and heat seal strength.
- the adhesive fluorine-containing polymer film has an adhesive fluorine-containing polymer force having an adhesive site.
- the above-mentioned adhesive fluorine-containing polymer should have the above-mentioned reactive functional group as an adhesive site.
- the above-mentioned adhesive fluorine-containing polymer film may form an adhesive fluorine resin layer described later.
- the above-mentioned adhesive fluorine-containing polymer may constitute an adhesive fluorine resin.
- the adhesive fluorine resin layer in the present invention is made of an adhesive fluorine resin.
- the adhesive fluorine resin is preferably a fluoropolymer having an adhesive site.
- the fluoropolymer is a polymer having a fluorine-containing monomer unit derived from a fluorine-containing monomer in the main chain. Further, the fluoropolymer may or may not have a fluorine-free monomer unit derived from a fluorine-free monomer.
- the “monomer unit” for the fluoropolymer means a part of a polymer molecular structure derived from a monomer. For example, a tetrafluoroethylene unit is represented by one (CF 3 -CF 3) —.
- the fluorine-containing monomer is not particularly limited as long as it is a polymerizable compound having a fluorine atom, and examples thereof include tetrafluoroethylene [TFE], vinylidene fluoride [VdF], black trifluoroethylene [ CTFE], vinyl fluoride [VF], hexafluoropropylene [HFP], hexafluoroisobutene, perfluoro (alkyl butyl ether) [PAVE] s, the following general formula (i):
- x 3 represents a hydrogen atom or a fluorine atom
- X 4 represents a hydrogen atom, a fluorine atom or a chlorine atom
- n represents an integer of 1 to 10
- the fluorine-free monomer is not particularly limited as long as it is a compound copolymerizable with the fluorine-containing monomer and does not have a fluorine atom.
- ethylene [Et] propylene, 1-butene, 2-butene
- vinyl chloride vinylidene chloride.
- fluoropolymer examples include the following copolymer (I) and the following copolymer ( ⁇ ).
- R 2 represents CF or —OR 1
- R 1 represents a perfluoroalkyl having 3 to 5 carbon atoms, f 3 ff
- Examples of the copolymer (I) include at least a copolymer having a TFE unit of 20 to 80 mol% and an Et unit of 80 to 20 mol%.
- the mol% for each monomer unit is the adhesive site-containing monomer unit described later, out of the total number of moles of the monomer from which the monomer unit constituting the molecular chain of the copolymer is derived.
- the model number Le excluding moles of monomer was decided that derived as 100 mole 0/0, a ratio of moles of monomer each monomer unit was to derived occupied in the 100 mole 0/0 is there.
- the mol% for each monomer unit is a value obtained from an F-NMR chart.
- the copolymer (I) may have other monomer units derived from other copolymerizable monomers in addition to the TFE unit and Et unit in the main chain.
- the monomer a monomer of a type corresponding to the use of the obtained laminated film can be appropriately selected and used for copolymerization.
- R 1 represents a perfluoroalkyl group having 1 to 5 carbon atoms
- copolymer (I) is preferred in terms of heat resistance, chemical resistance, weather resistance, electrical insulation, low liquid chemical permeability, non-adhesiveness, etc.
- EtZTFEZHFP copolymer is more preferable because of its excellent properties, chemical resistance, weather resistance, electrical insulation, low chemical permeability, non-adhesiveness, low-temperature processability, transparency and the like.
- the HFP unit in the above EtZTFEZHFP copolymer preferably has a lower limit of 8 mol%, more preferably 5 to 20 mol%, and a more preferable upper limit of 17 mol%.
- the EtZTFEZHFP copolymer is one kind of the above-mentioned other monomers other than the HFP unit, as long as the EtZTFEZHFP copolymer is preferred and does not lose its properties. Or you may have two or more.
- the “adhesive site” means a functional group having affinity or reactivity with the above-mentioned organic material such as polyimide [PI] film.
- affinity means a chemical structure such as hydrogen bond, van der Waals force, etc. It means a property that shows an interaction with an organic material such as a PI film that does not lead to a change, and “reactivity” means a property that changes a chemical structure such as a functional group.
- the adhesive site is usually one that the fluoropolymer has in the main chain or side chain.
- the fluoropolymer having a site there may be only one type of adhesive site, or two or more types of adhesive sites! /.
- the “adhesive site” may be the reactive functional group described above.
- the group or bond having a carbonyl group is preferably a carbonate group, a halogenoformyl group or the like from the viewpoint of easy introduction and high reactivity.
- R is an organic group, group IA Represents an atom, a group IV atom, or a group VIIB atom.
- Examples of the organic group for R in the above formula include an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms having an oxygen molecule constituting an ether bond, and preferably 1 to 8 carbon atoms. Or an alkyl group having 2 to 4 carbon atoms and having an oxygen molecule constituting an ether bond.
- the halogenoformyl group is represented by COY (wherein Y represents a VIIB group atom), and -COF, -COC1, and the like are preferable.
- the number of the adhesive sites may be appropriately selected depending on the type, shape, application, required adhesive strength, difference in the type of the fluoropolymer, and the like. 10 per 6 3 ⁇ : LOOO. When counting the number of carbonyl groups, the number of the above-mentioned adhesive sites is usually 150 or more, preferably 250 or more, more preferably 300 or more per 1 ⁇ 10 6 main chain carbon atoms. .
- the number of the “adhesive sites” is measured by performing an infrared absorption spectrum analysis in accordance with the method for measuring the number of carbonyl group-containing functional groups described in International Publication No. 99Z45044. is there.
- Examples of the adhesive fluorine resin include a fluorine-containing ethylenic polymer having a carbonyl group-containing functional group described in International Publication No. 99Z45044 pamphlet.
- the adhesive fluorine resin can be usually obtained by introducing an adhesive site in the production of a fluoropolymer by polymerization, but the method for introducing the adhesive site is not particularly limited.
- the method for introducing the adhesive site is not particularly limited.
- an adhesive site-containing monomer, a fluorine-containing monomer of a type and a composition depending on the target adhesive fluorine resin, and optionally a fluorine-free monomer are known. Can be carried out by copolymerization.
- the copolymerization method is not particularly limited, and is, for example, random copolymerization in which an adhesive site-containing monomer is introduced into the system when a polymer chain is formed with another comonomer such as a fluorine-containing monomer.
- block copolymerization or graft copolymerization may be used.
- draft copolymerization include a method in which an unsaturated carboxylic acid described later is attached to a fluoropolymer.
- the "adhesive moiety-containing monomer” means a polymerizable compound having an adhesive moiety, and may or may not have a fluorine atom.
- the above-mentioned “fluorine-containing monomer” and “fluorine-free monomer” are those having the above-mentioned adhesive part.
- Examples of the adhesive part-containing monomer include, when the adhesive part is a group having a carbo group or a bond, perfluoroacrylic acid fluoride, 1 fluoroacrylic acid fluoride, acrylic acid fluoride, 1 Monomers having fluorine such as trifluoromethacrylic acid fluoride and monofluorobutenoic acid; monomers having no fluorine such as acrylic acid, methacrylic acid, acrylic acid chloride and beylene carbonate.
- Examples of the adhesive site-containing monomer further include unsaturated carboxylic acids.
- the unsaturated carboxylic acids include aliphatic unsaturated carboxylic acids and acid anhydrides thereof.
- the aliphatic unsaturated carboxylic acid may be an aliphatic unsaturated monocarboxylic acid, or may be an aliphatic unsaturated polycarboxylic acid having two or more carboxyl groups.
- aliphatic unsaturated monocarboxylic acid C3-C20 aliphatic monocarboxylic acid etc., such as propionic acid, acrylic acid, methacrylic acid, crotonic acid, those acid anhydrides, etc. are mentioned, for example.
- examples of the aliphatic unsaturated polycarboxylic acid include maleic acid, fumaric acid, mesaconic acid, citraconic acid [CAC], itaconic acid, aconitic acid, itaconic anhydride [IAH], and citraconic anhydride [CAH]. .
- diisopropyl peroxy carbonate di-n-propyl peroxydicarbonate, t-butyl peroxy isopropyl carbonate, bis (4-tert-butyl cyclohexane) are used.
- the adhesive fluorine resin has a melting point of preferably 200 ° C or lower, more preferably 180 ° C or lower, from the viewpoint of the sealing property of the obtained laminated film.
- the melting point is a temperature at the maximum value of the melting peak obtained by measuring with a differential scanning calorimeter (Seiko Co., Ltd.) at a heating rate of 10 ° CZ.
- the adhesive fluorine-containing polymer film in the present invention may be in the form of a laminated film with a film other than the adhesive fluorine-containing polymer film.
- the laminated film in the present invention is a laminate of at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, and the adhesive fluorine-containing polymer film is at least one outermost surface.
- the number of layers may be two or more, but from the viewpoint of thermal conductivity to the contents, the force is 2 to 5 layers, preferably 2 and 3 layers, but is not limited thereto.
- the film thickness of the laminated film depends on the number of layers.
- the total film thickness is about 20 to 200 111, preferably about 20 to: LOO ⁇ m, particularly preferably about 20 to 60 ⁇ m, but is not limited thereto. It is not done.
- the thickness of the adhesive fluorine resin layer is preferably 5 to: LOO / zm, more preferably 10 ⁇ m or more and 50 ⁇ m or less.
- the adhesion strength (X) is generally 200 NZm or more, preferably 300 NZm or more, more preferably 40.
- the adhesive strength (X) is obtained by cutting a laminated film into a width of 10 mm, and using an edge of an adhesive fluororesin layer at the end and a film other than an adhesive fluorine-containing polymer film such as a PI film. This is the strength required when peeled off to make a grip and peeled 180 ° at a speed of 25 mmZ on a Tensilon universal testing machine.
- a film other than the above-mentioned adhesive fluorine-containing polymer film is not particularly limited unless it is a film having the above-mentioned adhesive fluorine-containing polymer power, but is preferably a cold-resistant resin. .
- the cold-resistant rosin refers to a rosin excellent in impact resistance at about -40 degrees or less, preferably about -80 degrees or less.
- ultra high molecular weight polyethylene, polyimide, polytetraflur Examples include fluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene vinyl acetate copolymer.
- polyimide, polytetrafluoroethylene, and ethylene Polytetrafluoroethylene copolymer is more preferable than polyimide.
- the molecular weight of cold-resistant rosin has a number average molecular weight of about 1,000 to 1,000,000, preferably ⁇ 2,000 to 500,000, more preferably ⁇
- the force that is about 5,000-300,000 is not limited to these.
- the above impact resistance is evaluated using a free fall dart impact test method (staircase method (JIS ⁇ 7124-1)) for a resin film or sheet immediately after removal from a frozen environment.
- a free fall dart impact test method staircase method (JIS ⁇ 7124-1)
- the 50% fracture energy ( ⁇ 50) in the above-mentioned staircase method liquid nitrogen temperature
- the above is preferable.
- the polyimide is not particularly limited as long as it has a heat-resistant polymer force having an imide bond in the main chain, for example, a non-thermoplastic polyimide having only an imide bond in the main chain, a wholly aromatic polyimide, an organic solvent soluble Forces including, but not limited to, polyimide, polyetherimide, and polyimideamide.
- the cold-resistant resin film includes, for example, a force obtained by forming a cold-resistant resin by a hot melting method, an extrusion method or a compression method and a solvent casting method at a high temperature and a high pressure. Is not to be done.
- Examples of the lamination of the adhesive fluorine-containing polymer film and the film other than the adhesive fluorine-containing polymer film in the laminated film include a heat laminating method, a heat compression method, a high-frequency heating method, and a solvent casting method. .
- the thermal lamination method is preferable from the viewpoint of ease of production, but is not limited thereto. Since the adhesive fluorine-containing polymer film adheres firmly to a film other than the above-mentioned adhesive fluorine-containing polymer film, the adhesive fluorine-containing polymer film may be peeled off from the film other than the adhesive fluorine-containing polymer film. Absent.
- the temperature condition in the thermal laminating method is a force of about 200 to 300 ° C., preferably about 200 to 250 ° C., from the viewpoint of safety in production and the like, but is not limited thereto.
- the laminated film in the present invention can be prepared by laminating a film other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film and an adhesive fluorine resin. Laminating of a film other than the adhesive fluorine-containing polymer film and the adhesive fluorine resin can be performed, for example, by an extrusion lamination method, or bonding with a film other than the adhesive fluorine-containing polymer film such as a PI film. It is also possible to carry out by adhering a functional fluorine resin by thermocompression bonding or the like.
- an extrusion process (a) in which the above-mentioned adhesive fluorine resin is melted and extruded onto a film other than the above-mentioned adhesive fluorine-containing polymer film such as the above-mentioned PI film (a), PI A crimping step (b) of crimping a film other than an adhesive fluorine-containing polymer film, such as a film, and an extruded adhesive fluororesin sandwiched between rolls, and a scraping step of scraping the resulting laminate (c)
- the extrusion process (a), the crimping process (b), and the scraping process (c) are performed in this order.
- the extrusion temperature in the extrusion step (a) depends on the type of film other than the adhesive fluorine-containing high molecular film such as the PI film used and the adhesive fluorine resin, the thickness of the target laminated film, etc. In general, it is preferably at least the melting point of the adhesive fluororesin used and less than the decomposition temperature in that a laminated film having a high interlayer adhesive strength can be obtained.
- the molten adhesive fluorine resin is extruded onto a film other than the adhesive fluorine-containing polymer film such as the PI film.
- the extrusion lamination is performed in an inert gas and includes an adhesive property such as a Z or PI film in that a laminated film having a high interlayer adhesive strength is obtained. It is preferable to remove water by drying or preheating a film other than the fluoropolymer film in advance.
- the extrusion lamination is present in the adhesive fluorocarbon resin by the extrusion process.
- the above-mentioned extrusion lamination is performed in an inert gas, and a film other than an adhesive fluorine-containing high molecular film such as a Z or PI film. It is considered that the above adhesiveness can be sufficiently exhibited when moisture is removed by drying or preheating the material in advance.
- the process conditions other than the above-described extrusion step (a) in the above-mentioned extrusion lamination are the types of films other than the adhesive fluorine-containing polymer film such as the PI film to be used, and the types of adhesive fluorine resin. Depending on the thickness of the laminated film, etc., it can be appropriately set according to a known method.
- the thermocompression bonding is preferably performed at a temperature of 120 to 300 ° C.
- the temperature is more preferably V lower limit of 140 ° C and more preferably upper limit of 280 ° C.
- the films other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film are laminated by thermocompression bonding or the like, they may be preheated prior to lamination or pre-dried. Also, when bonding each layer by thermocompression bonding, etc., in order to improve interlayer adhesion, it is possible to heat and age after bonding!
- the heating for the aging is preferably performed at 200 to 280 ° C.
- the laminated film is formed into a container or bag shape by a heat sealing method or the like. Specifically, two laminated films are stacked so that the adhesive fluorine-containing polymer films are in contact with each other, and heat sealing is performed.
- the inner volume of the container is generally about 2 to 200 ml, but is not limited to this.
- the width of the heat seal is not limited to this, which is about 2 to 20 mm, preferably about 5 to 15 mm, from the viewpoint of the sealing strength between the laminated films.
- the heat seal temperature is about 180 to 250 ° C, preferably about 200 to 220 ° C, from the viewpoint of the sealing strength between the laminated films.
- General-purpose fluororesin films cannot be sealed at temperatures as low as 180-250 ° C. In other words, the present invention Since the adhesive fluorine-containing polymer film has good heat sealability at low temperatures, the cost in the production process is also low.
- the cryopreservation container of the present invention contains, for example, blood components such as red blood cells, platelets, and plasma, and biological samples such as bone marrow fluid, other body fluids, and cell suspensions, and the contents when the cryopreservation container is damaged. It may be further packaged to protect materials and prevent liquid nitrogen from entering the cryopreservation container. As these packages, packages made of perfluoroethylenepropene copolymer are generally used, but are not limited thereto. At this time, the air between the cryopreservation container and the package can be easily degassed by using, for example, an auxiliary tool disclosed in Japanese Patent Application Laid-Open No. 2000-185716. It is not limited.
- the cryopreservation container of the present invention can be produced by forming the laminated film into a container or bag shape by a heat seal method or the like.
- the cryopreservation container uses a laminated film in which an adhesive fluoropolymer film is present on at least one outermost surface as the above-mentioned laminated film
- the cryopreservation container contains adhesiveness on at least one outermost surface.
- the container can be a container having a fluoropolymer film, and is preferably a container having an adhesive fluorine-containing polymer film at least on the outermost surface inside the container.
- the cryopreservation container of the present invention is capable of withstanding even at extremely low temperatures of -80 to 196 ° C. Forces Blood components such as erythrocytes, platelets and plasma, bone marrow fluid, other body fluids and cell suspensions In the case of actual storage, it is preferable to cool gradually in order not to damage these tissues.
- the power is not limited to this, for example, a method of once cooling it to about ⁇ 80 degrees with a deep freezer or the like and then storing it in liquid nitrogen.
- a heating means such as a 37-40 ° C. warm bath is not limited thereto.
- a commercially available storage solution can be appropriately used.
- the storage solution include DMEM medium, RPMY1640 medium, 199 medium, and phosphate buffer.
- DMEM medium Preferably, about 0.5 to 2% by volume of albumin may be added.
- dimethyl sulfoxide (DMSO) is used as a freezing protection agent. A final concentration of about 5-20% by volume may be added.
- Eurocollins solution and UW solution can be used.
- dimethyl sulfoxide (DMSO) may be added as a frost damage protective agent to a final concentration of about 5 to 20% by volume.
- the selection and preparation of these preservation solutions are not particularly limited because they can be appropriately selected by those skilled in the art.
- Examples of the method for freezing the cryopreservation container of the present invention containing or storing a biological sample include a method of freezing the cryopreservation container containing or storing a biological sample at 0 ° C or lower.
- a method of freezing at 80 ° C. or lower is preferable.
- the cryopreservation container is gradually cooled to a desired temperature and frozen in order not to damage the biological sample.
- Examples of such a freezing method include a method in which the cryopreservation container is once cooled to about 80 ° C. with a deep freezer (freezer) and then immersed in liquid nitrogen.
- the cryopreservation container may contain the above-described storage solution as necessary.
- the above cryopreservation container is usually kept frozen after being frozen by the above method.
- the cryopreservation container of the present invention has the above-described configuration, it does not break even at an extremely low temperature such as liquid nitrogen temperature (196 ° C), and the sealing performance at the sealed portion does not deteriorate. It can prevent the contamination and spillage of the contents that liquid refrigerant such as liquid nitrogen does not enter during freezing storage, and exhibits excellent protection performance.
- cryopreservation container is resistant to temperatures as low as the above-mentioned cryogenic temperatures as long as it is less than the melting point of the adhesive fluorocoagulant used. Therefore, even when the temperature is changed to a room temperature after being placed at the cryogenic temperature, there is no breakage and deterioration of the sealing performance at the sealing portion.
- the cryopreservation container of the present invention exhibits the above-mentioned excellent effects.
- (1 ) PI has extremely low temperature resistance that can maintain the shape of the molded body even at extremely low temperatures such as liquid nitrogen temperature.
- ( 3) The PI film and the adhesive fluororesin layer can be directly bonded without using an adhesive, and there is a problem when using an adhesive, that is, the adhesive layer is at a liquid nitrogen temperature.
- a laminated film formed by laminating a PI film and an adhesive fluororesin layer forms a cryopreservation container by thermally fusing the adhesive fluororesin layers to each other. It is considered that the properties of being excellent in adhesion between each other and reliable in sealing properties are synergistically exhibited.
- the cryopreservation container of the present invention can be suitably used as a cryopreservation container for biological samples.
- the cryopreservation container of the present invention is a container that can seal biological samples such as blood components, cells, tissues, organs, viruses, bacteria, sperm, eggs, fertilized eggs, and the like.
- Examples of the blood components include whole blood, red blood cells, white blood cells, plasma, platelets, and platelet-rich plasma.
- the cells include hematopoietic stem cells, ES cells, mesenchymal stem cells, skeletal mononuclear cells, rare cells such as sperm cells and egg cells, and general cells such as nerve cells, epithelial cells, fibroblasts, etc. Is mentioned.
- tissue as various tissues such as tendons, nerves, ligaments, esophagus, trachea, and spleen, as well as membrane tissues and organs such as mucosal epithelial tissue, corneal epithelial tissue and cultured corneal tissue
- examples include the spleen, heart, lungs, liver and kidneys.
- viruses include hepatitis B virus, hepatitis C virus, coronavirus, and mosaic virus.
- the bacteria include tuberculosis bacteria, Haemophilus influenzae, Escherichia coli, Staphylococcus aureus, hemolyzed staphylococci, and Klebsiella pneumoniae.
- sperm, ovum and fertilized egg are mentioned in the field of infertility treatment, for example.
- These stored blood or blood components, cells containing rare cells, and other biological tissues are selected according to the purpose of the operator and are not particularly limited.
- biological tissue examples include biological fluids (blood, cerebrospinal fluid, lymph, etc.) and components thereof (red blood cells, white blood cells, platelets, plasma, serum, etc.), and biological tissues (blood vessels, cornea, Meniscus, brain tissue, skin, subcutaneous tissue, epithelial tissue, bone tissue, muscle tissue, etc.), organs (eye, lung, kidney, heart, liver, spleen, spleen, digestive tract, bladder, ovary, testis, etc.), various Cells (such as cord blood, hematopoietic stem cells such as peripheral blood-derived hematopoietic stem cells, bone marrow cells, hepatocytes, spleen cells and brain cells) Various organ cells, nerve cells, sperm, egg cells, fertilized eggs, embryonic stem cells (ES cells), cancer cells for research and treatment, cultured cells, stem cells, embryo cells, etc.).
- biological fluids blood, cerebrospinal fluid, lymph, etc.
- components thereof red blood cells, white blood cells, platelets, plasma
- Examples of the biological sample include human biological tissues and genetic related substances, as well as biological tissues and genetic related substances of animals including small animals such as small experimental animals; microorganisms, bacteria, and genetic related substances thereof. These include, for example, those used in the research field.
- Examples of the biological sample also include livestock / animal biological tissues and genetic materials, and examples thereof include those used in the agricultural field such as research, culture, cultivation, and horticulture.
- Examples of the biological sample also include plant seeds, pollen, cultured cells, shoot apical cells, and genetic materials.
- biological sample examples include biological tissues such as marine algae and fish and genetic related substances, and examples thereof include those used in the field of fisheries such as research.
- Examples of the above-mentioned gene-related substances include DNA, host, vector and the like.
- the biological sample is, for example, for medical use; for research and development in the fields of agriculture, forestry, fisheries, horticulture, etc .; for animal treatment, fertility treatment, etc. in the pet industry and animal industry. It can be used for related purposes, cloning techniques, etc.
- cryopreservation container of the present invention can be used in various fields such as medicine; research; agriculture such as livestock and horticulture;
- polyimide film 8-component random copolymer film (hereinafter referred to as inner layer fluororesin film and outer layer fluororesin film, respectively)
- inner layer fluororesin film and outer layer fluororesin film Two-layer and three-layer films were prepared by the heat laminating method. Two sheets of the above film cut to a size of 180 x 100 mm are stacked so that the inner fluororesin film is in contact with each other, and the edge 10 mm is heat-sealed by the heat seal method to form a cryopreservation container. Created. Table 1 shows the film thickness of each film layer.
- the copolymer composition ratio of the above three-component random copolymer film is as follows: perfluoro (1, 1, 9, 9—tetrahydride 1, 2, 5-bistrifluoromethyl 1, 3, 6—dioxa 8—nonenor )
- perfluoro 1, 9, 9—tetrahydride 1, 2, 5-bistrifluoromethyl 1, 3, 6—dioxa 8—nonenor
- monomer unit 1 the total number of polytetrafluoroethylene monomer units and perfluoro (bulupropyl ether) monomer units was 99.
- the copolymer composition ratio was measured by 19 F-NMR.
- Comparative Example 1 Comparative cryopreservation container 1
- a commercially available cryopreservation container (manufactured by BAXER) made of an ethylene-vinyl acetate copolymer was used.
- Comparative Example 2 Comparative cryopreservation container 2
- a commercially available cryopreservation container made of polyethylene (CharterMed) was used.
- the inside temperature was kept at 35 ° C and the stirring speed was kept at 200 rpm. Further, tetrafluoroethylene was injected into 7.25 kgZcm 2 G, and then ethylene was injected into 8 kgZcm 2 G.
- the polymerization was conducted for a total of 32 hours. After polymerization is complete, the contents are recovered, washed with water, and contacted with powder. 95 kg of adhesive fluorocoagulant was obtained.
- N 500AW / ⁇ df
- the temperature was measured at a rate of temperature increase of 10 ° CZ, and the temperature at the maximum value of the melting peak obtained was taken as the melting point.
- Example 9 A T-die is connected to a single-screw extruder with a cylinder diameter of 90 mm using the adhesive fluorine resin obtained from the synthesis example, the cylinder temperature is 170 to 230 ° C, the die temperature is 230 ° C, the screw An adhesive fluororesin film (thickness: 25 m) was molded under the condition of the number of revolutions lOrpm.
- the adhesive fluororesin film obtained and a polyimide film product name: Kapton 100H, manufactured by Toray DuPont, thickness: 25 ⁇ m
- Kapton 100H manufactured by Toray DuPont, thickness: 25 ⁇ m
- a laminated film (length 20 m ⁇ width 200 mm ⁇ total thickness 50 ⁇ , hereinafter referred to as a long film) was obtained.
- the resulting laminated film (fluorine-resin layer thickness: 25 m, polyimide layer thickness: 25 / zm) was cut into a strip of 100 mm in the length direction and 10 mm in the width direction, and its edges Fluorine resin layer and polyimide layer were peeled off using a blade to make a margin, and measured using a Tensilon universal testing machine (Orientec Co., Ltd.) 180 ° peeled at a rate of 25 mmZ, measured at 400 NZm. there were.
- cryopreservation container of the present invention can sufficiently cope with liquid nitrogen immersion.
- cryopreservation containers prepared in Examples 1 to 9 and the cryopreservation containers of Comparative Examples 1 and 2 were each filled with 80 ml of a dimethyl sulfoxide (DMSO) 10% (vZv) aqueous solution, and the air was sufficiently evacuated. Housed in an aluminum case. Dee container stored in aluminum case It was left to stand at 80 ° C for 4 hours in a freezer (freezer) and frozen. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and the container was visually inspected for damage and liquid nitrogen contamination.
- DMSO dimethyl sulfoxide
- Table 2 shows the results of the experiment. While Comparative Example 1 was damaged by 20% and Comparative Example 2 was broken by 10%, the cryopreservation container of the present invention had a huge number of tests of 30 pieces, but it was not damaged. I got it.
- Example 9 Each of the cryopreservation container and the cryopreservation container of Comparative Example 1 were filled with 80 ml of a cell suspension of dimethylsulfoxide (DMSO) 10% (v / v), fully evacuated, and then made of aluminum. Stored in a case. The container housed in the aluminum case was frozen at 80 ° C for 4 hours using a deep freezer. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and visually inspected the container for damage and liquid nitrogen contamination. Each test was conducted 5 times.
- DMSO dimethylsulfoxide
- the cryopreservation container of the present invention makes it possible to store blood, rare cells, and biological tissues without damage in a cryogenic environment.
- the film thickness is relatively thin, the thermal conductivity to the contents of the cryopreservation container is not reduced.
- the sealability by heat sealing after storing the cryopreservation container is very good, it is possible to prevent the inside of the liquid nitrogen from being mixed, and contamination and thawing by bacteria or viruses in the liquid nitrogen. It is possible to prevent the cryopreservation container from rupturing due to the expansion of mixed liquid nitrogen.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Environmental Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
- Packages (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Wrappers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Bag Frames (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
明 細 書 Specification
凍結保存容器およびその製造方法 Cryopreservation container and manufacturing method thereof
技術分野 Technical field
[0001] 本発明は、凍結保存容器、その製造方法に関する。具体的には、少なくとも接着性 含フッ素高分子フィルムからなる凍結保存容器、好ましくは、少なくとも接着性含フッ 素高分子フィルムと、耐寒性榭脂フィルムを含む積層フィルムで構成され、該積層フ イルムの少なくとも片面が接着性含フッ素高分子フィルムである凍結保存容器に関す る。 [0001] The present invention relates to a cryopreservation container and a method for producing the same. Specifically, a cryopreservation container comprising at least an adhesive fluorine-containing polymer film, preferably a laminate film including at least an adhesive fluorine-containing polymer film and a cold-resistant resin film, the laminate film. The invention relates to a cryopreservation container in which at least one surface of the film is an adhesive fluorine-containing polymer film.
背景技術 Background art
[0002] 血液、稀少細胞および生体組織などの保存は、 80〜一 196°C程度の極低温下で 保存する方法が一般的である。特に骨髄細胞、造血幹細胞などの稀少細胞は、白血 病などの難病治療に効果を有するものであり、長期保存の技術が求められている。こ のような極低温下での保存には、上記血液、稀少細胞および生体組織などを収容す る容器に入れ、密封し、主に液体窒素内で保存することが一般的である。 [0002] In general, blood, rare cells, living tissues, and the like are stored at a cryogenic temperature of about 80 to 196 ° C. In particular, rare cells such as bone marrow cells and hematopoietic stem cells are effective in treating intractable diseases such as leukemia, and long-term storage techniques are required. For such storage at extremely low temperatures, it is general to place the container in a container containing the blood, rare cells, living tissue, etc., seal it, and store it mainly in liquid nitrogen.
[0003] 保存に使用する凍結保存容器は、例えば、実験室レベルでポリプロピレン製のノ ィ アルが市販されており、安価で取り扱 、上便利である。 [0003] As cryopreservation containers used for storage, for example, polypropylene-made needles are commercially available at the laboratory level, and are inexpensive and easy to handle.
また、近年臍帯血バンクの発展に伴い、耐寒性、可撓性に優れた袋状の容器が提案 されている。例えば、ポリイミドフィルムとフッ素化工チレンプロピレン重合体フィルムと の積層フィルム力 なるもの(特許文献 1)や、テトラフルォロエチレンとエチレンの共 重合体フィルム力もなるもの(特許文献 2)等が提案されている。さらに、特許文献 3に は、電子線照射し 2軸延伸されたエチレン 酢酸ビニル共重合体のフィルムで成形 された凍結保存容器が開示されている。特許文献 4には、 2軸延伸された架橋ポリェ チレンフィルムで成形された凍結保存容器が開示されている。 In recent years, with the development of the cord blood bank, a bag-like container excellent in cold resistance and flexibility has been proposed. For example, a film having a laminated film strength of a polyimide film and a fluorinated ethylene propylene polymer film (Patent Document 1), a film having a film power of a copolymer of tetrafluoroethylene and ethylene (Patent Document 2), etc. have been proposed. ing. Furthermore, Patent Document 3 discloses a cryopreservation container formed of a film of an ethylene vinyl acetate copolymer that has been biaxially stretched by electron beam irradiation. Patent Document 4 discloses a cryopreservation container formed of a biaxially stretched crosslinked polyethylene film.
[0004] しかしながら、特許文献 1および 2に開示されたフッ素系榭脂は融点が高ぐ高温で のヒートシールでの製造が求められるために、成型カ卩ェ性に乏しぐこのような過酷な 条件で製造したにも関わらずシール強度が弱いために、凍結保存時にしばしば破損 することがある。また、特許文献 3および 4に開示された延伸フィルムではヒートシール 操作によってシール部分及びその周辺でフィルムが収縮してしわになり、実際の使 用においては手荒な取扱いをするとしばしば破損する場合がある。さらに、特許文献[0004] However, the fluorocarbon resins disclosed in Patent Documents 1 and 2 are required to be manufactured by heat sealing at a high temperature with a high melting point. Despite being manufactured under the conditions, the seal strength is weak, so it often breaks during cryopreservation. In addition, the stretched film disclosed in Patent Documents 3 and 4 is heat sealed. The film shrinks and wrinkles in the seal area and its surroundings due to the operation, and in actual use, it may often be damaged by rough handling. In addition, patent literature
3の積層フィルムはポリエステル、ポリウレタンおよびエポキシ等の接着剤により接着 されているため、低温保存中に接着層が硬化し、積層フィルムが剥離してくることがあ り、凍結保存容器としては決して適するものではない。 Since the laminated film of 3 is bonded with an adhesive such as polyester, polyurethane and epoxy, the adhesive layer may harden during low-temperature storage, and the laminated film may peel off, making it suitable as a cryopreservation container. It is not a thing.
[0005] 一方、超高分子量ポリエチレンは、耐衝撃性、耐摩耗性、自己膨潤性、耐薬品性、 耐寒性および無毒性である点で非常に優れて 、るものの、極めて高!、溶融粘度を有 しているため、フィルムの製造方法は通常、粉末の原料レジンを圧縮成形等でブロッ ク状成形品とした後、切削加工によって作製している。上記のように製造されたフィル ムでは、その表面状態が粗面となっているので成形力卩ェは決して容易ではない。ま た、ノ リがあるとフィルム表面のポリエチレンが脱落する可能性があり、医療用バッグ として用いた場合、異物混入の原因となる。また、圧縮加工成形は成形時にエアが 取り込まれた状態になりやすぐ次の工程で切削されたフィルムにピンホールが生じ る可能性がある。 [0005] On the other hand, ultrahigh molecular weight polyethylene is very excellent in that it is impact resistant, abrasion resistant, self-swelling, chemical resistant, cold resistant and non-toxic, but it is extremely high !, melt viscosity Therefore, the film production method is usually made by cutting a powdery raw material resin into a block-shaped product by compression molding or the like. In the film manufactured as described above, since the surface state is rough, the molding force is not easy. In addition, there is a possibility that polyethylene on the surface of the film may fall off if there is a paste, and if used as a medical bag, it may cause contamination. In compression molding, air is taken in at the time of molding, and pinholes may occur in the film cut in the next process.
またシート同士あるいはシートとポート部品をヒートシールする場合、超高分子量ポリ エチレンは分子量が 100万以上と高いため、ポリエチレン分子鎖の流動性が悪い。 そのためヒートシールが難しぐ容器の安定した製造に問題があった。 In addition, when heat-sealing between sheets or between a sheet and a port part, the molecular weight of ultra-high molecular weight polyethylene is as high as 1 million or more, so the fluidity of polyethylene molecular chains is poor. Therefore, there is a problem in stable production of containers that are difficult to heat seal.
[0006] 芳香族ポリイミドを用いた凍結保存容器としては、該ポリイミドを外層とし、無延伸ポリ エチレンを内層とする積層体が提案されている (例えば、特許文献 5参照。 ) 0この積 層体は、内層の熱融着により袋形状ィ匕は可能力もしれないが、ポリイミドの非溶融カロ ェ性により、内層との積層をヒートロール等による熱ラミネーシヨンにより行うことができ ず、接着剤を介在させる必要があり、上述の接着剤の問題が依然として残ってしまう [0006] The cryopreservation container using the aromatic polyimide, the polyimide is an outer layer, the laminate of the non-oriented poly ethylene and the inner layer has been proposed (e.g., see Patent Document 5.) 0 The product Sotai However, due to the heat fusion of the inner layer, the bag shape may not be possible, but due to the non-melting calorific properties of polyimide, lamination with the inner layer cannot be performed by thermal lamination using a heat roll or the like, and an adhesive is not used. Need to intervene and the above adhesive problem still remains
[0007] 特許文献 1:特公昭 49— 008079号公報 [0007] Patent Document 1: Japanese Patent Publication No.49-008079
特許文献 2:実公昭 55— 055069号公報 Patent Document 2: Japanese Utility Model Publication No. 55-055069
特許文献 3:特公昭 55— 044977号公報 Patent Document 3: Japanese Patent Publication No. 55-044977
特許文献 4:特公昭 62— 057351号公報 Patent Document 4: Japanese Patent Publication No. 62-057351
特許文献 5:特開平 7— 246230号公報 発明の開示 Patent Document 5: Japanese Patent Laid-Open No. 7-246230 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0008] 以上のことから、容器の安定した製造、特に低温ヒートシール性に優れた凍結保存 容器の開発が求められている。さらに、そのシール強度に優れたものであり、凍結保 存時に容器が破損しにく 、凍結保存容器の開発が求められて 、る。 [0008] From the above, there is a demand for the stable production of containers, particularly the development of cryopreservation containers excellent in low-temperature heat sealability. Furthermore, it has excellent sealing strength, and it is difficult to break the container during freezing storage, so the development of a cryopreservation container is required.
課題を解決するための手段 Means for solving the problem
[0009] 本発明者らは、接着性含フッ素高分子フィルムを凍結保存容器に用いることを提案 する。 [0009] The present inventors propose to use an adhesive fluorine-containing polymer film for a cryopreservation container.
つまり、本発明は、 In other words, the present invention
[1] 少なくとも接着性含フッ素高分子フィルムを含む凍結保存容器、 [1] A cryopreservation container containing at least an adhesive fluorine-containing polymer film,
[2] 接着性含フッ素高分子フィルムは接着性部位を有する含フッ素高分子からなる [2] Adhesive fluorine-containing polymer film is composed of a fluorine-containing polymer having an adhesive site
[1]に記載の凍結保存容器、 The cryopreservation container according to [1],
[3] 接着性部位が、炭素-炭素二重結合、カルボニル基 [—C ( =〇)]、カルボ二 ル基を有する基又は結合、ヒドロキシル基、シァノ基、スルホン酸基、およびエポキシ 基力 なる群より選択される少なくとも 1つである [2]に記載の凍結保存容器、 [3] Adhesive sites are carbon-carbon double bond, carbonyl group [—C (= 〇)], group or bond having a carbonyl group, hydroxyl group, cyano group, sulfonic acid group, and epoxy group The cryopreservation container according to [2], which is at least one selected from the group consisting of:
[4] 接着性含フッ素高分子が、接着性部位として反応性官能基を有しており、以下 の (A)と (B)を共重合して得られる共重合体である [3]に記載の凍結保存容器: [4] The adhesive fluorine-containing polymer has a reactive functional group as an adhesive site, and is a copolymer obtained by copolymerizing the following (A) and (B): [3] Described cryopreservation container:
(A) 反応性官能基を有さない含フッ素モノマー (A) Fluorine-containing monomer having no reactive functional group
(B) 少なくとも 1種類の反応性官能基を有する含フッ素モノマー、 (B) a fluorine-containing monomer having at least one reactive functional group,
[5] 反応性官能基を有さない含フッ素モノマーが、以下の式(1)で表現される [4] に記載の凍結保存容器: [5] The cryopreservation container according to [4], wherein the fluorine-containing monomer having no reactive functional group is represented by the following formula (1):
[化 1] cx! 2=cx2 [Chemical 1] cx ! 2 = cx 2
(式中の X1および X2はそれぞれ水素原子またはハロゲン原子であり、 Yは水素原子 、フッ素原子、炭素数 1〜5の含フッ素アルキル基または炭素数 1〜5の含フッ素ォキ シアルキル基である)、 (In the formula, X 1 and X 2 are each a hydrogen atom or a halogen atom, and Y is a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or a fluorine-containing alkyl group having 1 to 5 carbon atoms. Is a alkyl group),
[6] 反応性官能基を有さない含フッ素モノマー力 テトラフルォロエチレン、フツイ匕 ビニリデン、 1, 2—ジフノレオ口クロ口エチレン、へキサフノレオ口プロピレン、パーフノレオ 口(ビュルメチ Cルエーテル)およびパーフルォロ(ビュルプロピルエーテル)力 なる群 より選択される少なくとも 1つである [5]に記載の凍結保存容器、 [6] Fluorine-containing monomer power without reactive functional groups Tetrafluoroethylene, Futsui vinylidene, 1,2-difunoleo-ethylene, hexafnoreo-propylene, perfluoronole (bulumetyl ether) and perfluoro ( The cryopreservation container according to [5], which is at least one selected from the group consisting of
[7] 反応性官能基を有する含フッ素モノマーが、以下の式 (2)で表現される [4]〜 [ [7] A fluorine-containing monomer having a reactive functional group is represented by the following formula (2) [4] to [
6]に記載の凍結保存容器: [6] Cryopreservation container:
[化 2] [Chemical 2]
CX1; CX 1 ;
(¾ (¾
(式中の X1および X2はそれぞれ水素原子またはハロゲン原子であり、 Zはヒドロキシ ル基、カルボキシル基、シァノ基、スルホン酸基またはエポキシ基であり、 Rは炭素数 f (In the formula, X 1 and X 2 are each a hydrogen atom or a halogen atom, Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group, and R is a carbon number f.
1〜40の含フッ素アルキレン基、炭素数 1〜40の含フッ素ォキシアルキレン基または 炭素数 1〜40の少なくとも 1つのエーテル結合を有する含フッ素アルキレン基である )、 A fluorinated alkylene group having 1 to 40 carbon atoms, a fluorinated oxyalkylene group having 1 to 40 carbon atoms, or a fluorinated alkylene group having at least one ether bond having 1 to 40 carbon atoms).
[8] 接着性含フッ素高分子が、以下の式 (3)で表現される [4]に記載の凍結保存 容器: [8] The cryopreservation container according to [4], wherein the adhesive fluorine-containing polymer is represented by the following formula (3):
[化 3] [Chemical 3]
(式中の χ1および ΧΊまそれぞれ水素原子またはハロゲン原子であり、 Υ1および γ2は それぞれ水素原子、フッ素原子、炭素数 1〜5の含フッ素アルキル基または炭素数 1 〜5の含フッ素アルコキシ基であり、 Ζはヒドロキシル基、カルボキシル基、シァノ基、 スルホン酸基またはエポキシ基であり、 Rは炭素数 1〜40の含フッ素アルキレン基、 (In the formula, χ 1 and ΧΊ are each a hydrogen atom or a halogen atom, and Υ 1 and γ 2 are a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a fluorine-containing group having 1 to 5 carbon atoms, respectively. Is an alkoxy group, and Ζ is a hydroxyl group, a carboxyl group, a cyano group, A sulfonic acid group or an epoxy group, and R is a fluorine-containing alkylene group having 1 to 40 carbon atoms,
f f
炭素数 1〜40の含フッ素ォキシアルキレン基または炭素数 1〜40の少なくとも 1つの エーテル結合を有する含フッ素アルキレン基であり、 (1+m) Zn力 〜 2000である) A fluorine-containing oxyalkylene group having 1 to 40 carbon atoms or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn force is 2000
[9] 接着性含フッ素高分子は、含フッ素モノマーに由来する含フッ素モノマー単位 と、フッ素非含有モノマーに由来するフッ素非含有モノマー単位とを有するものであ る [3]に記載の凍結保存容器、 [9] The adhesive fluorine-containing polymer has a fluorine-containing monomer unit derived from a fluorine-containing monomer and a fluorine-free monomer unit derived from a fluorine-free monomer. Container,
[10] 含フッ素モノマーはテトラフルォロエチレンであり、フッ素非含有モノマーはェ チレンである [9]に記載の凍結保存容器、 [10] The cryopreservation container according to [9], wherein the fluorine-containing monomer is tetrafluoroethylene, and the fluorine-free monomer is ethylene.
[11] 少なくとも接着性含フッ素高分子フィルムと、該接着性含フッ素高分子フィル ム以外のフィルムを含む積層フィルムで構成され、該接着性含フッ素高分子フィルム が少なくとも片方の最外面に存在する [1]に記載の凍結保存容器、 [11] It is composed of a laminated film including at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, and the adhesive fluorine-containing polymer film is present on at least one outermost surface. The cryopreservation container according to [1],
[12] 該接着性含フッ素高分子フィルム以外のフィルムが、耐寒性榭脂フィルムであ る [11]に記載の凍結保存容器、 [12] The cryopreservation container according to [11], wherein the film other than the adhesive fluorine-containing polymer film is a cold-resistant resin film,
[13] 耐寒性榭脂が、超高分子量ポリエチレン、ポリイミド、ポリテトラフルォロェチレ ン、エチレンーテトラフルォロエチレン共重合体およびエチレン 酢酸ビュル共重合 体力 なる群より選択される少なくとも 1つである [12]に記載の凍結保存容器、 [14] 耐寒性榭脂が、ポリイミドである [13]に記載の凍結保存容器、 [13] The cold-resistant resin is at least one selected from the group consisting of ultrahigh molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene acetate butyl copolymer The cryopreservation container according to [12], [14] The cryopreservation container according to [13], wherein the cold-resistant rosin is polyimide,
[15] 少なくとも接着性含フッ素高分子フィルムを、ヒートシールにより袋状に成形す ることを特徴とする凍結保存容器の製造方法、 [15] A method for producing a cryopreservation container, wherein at least an adhesive fluorine-containing polymer film is formed into a bag shape by heat sealing,
および [16] 少なくとも接着性含フッ素高分子フィルムと、該接着性含フッ素高分子 フィルム以外のフィルムを含み、該接着性含フッ素高分子フィルムが少なくとも片方 の最外面に存在する積層フィルムを、ヒートシールにより袋状に成形することを特徴と する [15]に記載の凍結保存容器の製造方法に関する。 And [16] A laminated film including at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, wherein the adhesive fluorine-containing polymer film is present on at least one outermost surface is heated. The present invention relates to the method for producing a cryopreservation container according to [15], which is formed into a bag shape with a seal.
発明の効果 The invention's effect
本発明の凍結保存容器は、低温でもヒートシール可能であるために、過酷な条件で ノ ッグを製造することがなぐ容器の安定した製造を可能にする。さらに、ヒートシ一 ル強度が強いために、凍結保存時における容器の破損を防止することができ、例え ば貴重な生体試料等を安定して保存することができる。 Since the cryopreservation container of the present invention can be heat-sealed even at a low temperature, the container can be stably manufactured without manufacturing the noggles under severe conditions. In addition, because the heat seal strength is strong, it is possible to prevent the container from being damaged during cryopreservation. Precious biological samples can be stably stored.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
[0011] 本発明の凍結保存容器は、少なくとも接着性含フッ素高分子フィルムを含むものであ る。 [0011] The cryopreservation container of the present invention includes at least an adhesive fluorine-containing polymer film.
上記接着性含フッ素高分子フィルムとは、主鎖および Zまたは側鎖に少なくとも 1つ のフッ素原子を有する高分子で成形されたフィルムであり、該フィルムは有機材料か らなる基材に接着する機能を有するものをいう。ここで接着とは、上記有機材料に上 記接着性含フッ素高分子フィルムが、物理的および Zまたは化学的結合などにより 結合することをいい、結合強度の観点から、化学的結合が好ましいが、これに限定さ れるものではない。上記化学的結合とは、共有結合、イオン結合、配位結合、水素結 合および分子間力などが挙げられ、結合の強度の観点から、好ましくは共有結合お よびイオン結合、さらに好ましくは共有結合である力 これに限定されるものではない The adhesive fluorine-containing polymer film is a film formed of a polymer having at least one fluorine atom in the main chain and Z or side chain, and the film adheres to a substrate made of an organic material. It has a function. Here, the term “adhesion” means that the above-mentioned adhesive fluorine-containing polymer film is bonded to the organic material by physical and Z or chemical bonding. From the viewpoint of bonding strength, chemical bonding is preferable. It is not limited to this. Examples of the chemical bond include a covalent bond, an ionic bond, a coordination bond, a hydrogen bond, and an intermolecular force. From the viewpoint of bond strength, the bond is preferably a covalent bond and an ionic bond, and more preferably a covalent bond. Is not limited to this force
[0012] また、上記有機材料とは、ポリエチレン、ポリカーボネート、ポリスチレン、ポリ塩化ビ[0012] The organic material includes polyethylene, polycarbonate, polystyrene, and polyvinyl chloride.
-ル、ポリ酢酸ビュル、ポリエステルならびに超高分子量ポリエチレン、ポリイミド、ポリ テトラフルォロエチレン、エチレンーテトラフルォロエチレン共重合体およびエチレン 酢酸ビニル共重合体などの耐寒性榭脂からなるフィルム、チューブ、合成繊維、合 成ゴムおよび固形物などの汎用の榭脂成形品、ならびに天然ゴム、天然繊維、木材 、紙類および皮革類などの天然の有機物をいい、さらに、上記接着性含フッ素高分 子自体も含む。中でも、凍結保存容器自身の耐寒性の向上の観点から、接着性含フ ッ素高分子フィルム自身および耐寒性榭脂フィルムと接着する機能を有する有機材 料と接着可能であることが好ましいが、これに限定されるものではない。 -Films made of cold-resistant resin such as rubber, polyacetate butyl, polyester and ultra high molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer and ethylene vinyl acetate copolymer, General purpose resin molding products such as tubes, synthetic fibers, synthetic rubbers and solid materials, and natural organic materials such as natural rubber, natural fibers, wood, papers and leathers. Includes the molecule itself. Among them, from the viewpoint of improving the cold resistance of the cryopreservation container itself, it is preferable that it can be adhered to an organic material having a function of adhering to the adhesive fluorine-containing polymer film itself and the cold resistant resin film. It is not limited to this.
[0013] 上記接着性含フッ素高分子の分子量は、その成形加工性の観点から、数平均分子 量で約 1, 000〜1, 000, 000、好まし <は約 2, 000〜500, 000、さらに好まし <は 約 5, 000〜300, 000である力 これに限定されるものではない。 [0013] From the viewpoint of molding processability, the molecular weight of the above-mentioned adhesive fluorine-containing polymer is about 1,000 to 1,000,000, preferably <is about 2,000 to 500,000 in terms of number average molecular weight. More preferred, <is a force that is about 5,000-300,000, but is not limited to this.
[0014] 上記接着性含フッ素高分子フィルムは、接着性含フッ素高分子の分子構造、ガラス 転移温度および融点などによって、当業者が適時好適な製造方法を選択して製造 することができる。例えば、圧縮成形、射出成形、押出成形、 τダイ成形、インフレ一 シヨン成形および溶剤キャスティング法などが挙げられ、成形加工性の観点から圧縮 成形が好ましいが、これに限定されるものではない。また、上記接着性含フッ素高分 子フィルムの膜厚は、内容物への熱伝導度の観点から、約 10〜: LOO /z m 好ましく は 10〜50 μ m、特に好ましくは 10〜30 μ mであるが、これに限定されるものではな い。 [0014] The above-mentioned adhesive fluorine-containing polymer film can be produced by a person skilled in the art selecting a suitable production method in a timely manner according to the molecular structure of the adhesive fluorine-containing polymer, the glass transition temperature, the melting point, and the like. For example, compression molding, injection molding, extrusion molding, τ die molding, inflation Examples include sill molding and solvent casting, and compression molding is preferred from the viewpoint of molding processability, but is not limited thereto. The film thickness of the adhesive fluorine-containing polymer film is about 10 to: LOO / zm, preferably 10 to 50 μm, and particularly preferably 10 to 30 μm, from the viewpoint of thermal conductivity to the contents. However, the present invention is not limited to this.
[0015] 上記接着性含フッ素高分子の好ま 、態様としては、以下の (A)および (B)を含む 共重合体が例示される。 [0015] Preferred examples of the above-mentioned adhesive fluorine-containing polymer include a copolymer containing the following (A) and (B).
(A) 反応性官能基を有さない含フッ素モノマー。 (A) A fluorine-containing monomer having no reactive functional group.
(B) 少なくとも 1種類の反応性官能基を有する含フッ素モノマー。 (B) A fluorine-containing monomer having at least one reactive functional group.
[0016] 本発明における反応性官能基とは、上記有機材料からなる基材に共有結合、イオン 結合、配位結合および水素結合などより接着することができる官能基であり、例えば 、ヒドロキシル基、カルボキシル基、シァノ基、スルホン酸基およびエポキシ基などが 挙げられる。中でも熱により容易に活性ィ匕されるヒドロキシル基が好ましいが、これに 限定されるものではない。 [0016] The reactive functional group in the present invention is a functional group capable of adhering to the base material made of the organic material through a covalent bond, an ionic bond, a coordinate bond, a hydrogen bond, and the like. Examples thereof include a carboxyl group, a cyano group, a sulfonic acid group, and an epoxy group. Among them, a hydroxyl group that is easily activated by heat is preferable, but is not limited thereto.
[0017] 上記含フッ素モノマーとは、重合により得られる共重合体の主鎖および Zまたは側鎖 の少なくとも 1つの水素原子がフッ素に置換された共重合体が得られるものであり、 例えば、含フッ素エチレン性モノマー、含フッ素エステル性モノマーおよび含フッ素 全芳香族性モノマーなどが挙げられる。中でも入手が容易であり、得られる共重合体 の成形カ卩ェ性の観点から、含フッ素エチレンモノマーが好ましいが、これに限定され るものではない。 [0017] The fluorine-containing monomer is a monomer in which at least one hydrogen atom in the main chain and Z or side chain of the copolymer obtained by polymerization is substituted with fluorine. Examples thereof include fluorine ethylenic monomers, fluorine-containing ester monomers, and fluorine-containing wholly aromatic monomers. Among these, a fluorine-containing ethylene monomer is preferable from the viewpoint of easy availability and molding moldability of the resulting copolymer, but is not limited thereto.
[0018] 上記共重合体は、(A)および (B)それぞれ少なくとも 1種類ずつを重合した 2成分系 であればよい。例えば、 1種類の(A)のモノマーと、 1種類の(B)のモノマーからなる 2 成分系、 2種類の(A)のモノマーと、 1種類の(B)のモノマーからなる 3成分系および 1種類の(A)のモノマーと、 2種類の(B)のモノマーからなる 3成分系などが挙げられ る。中でも、製造のコストの観点から 2または 3成分系であることが好ましいが、これに 限定されるものではない。 [0018] The copolymer may be a two-component system obtained by polymerizing at least one of each of (A) and (B). For example, a two-component system consisting of one (A) monomer and one (B) monomer, a three-component system consisting of two (A) monomers and one (B) monomer, and Examples include a three-component system composed of one type of monomer (A) and two types of monomer (B). Of these, a two- or three-component system is preferable from the viewpoint of production cost, but is not limited thereto.
[0019] 上記共重合は、ラジカル共重合、ァニオン共重合、カチオン共重合、乳化共重合お よびプラズマ共重合などが挙げられ、モノマーの構造、極性、溶媒の種類などにより 当業者が適時選択できるものである。中でも製造容易性の観点力 ラジカル共重合 が好まし!/、が、これに限定されるものではな!/、。 [0019] Examples of the copolymer include radical copolymerization, anion copolymerization, cationic copolymerization, emulsion copolymerization, and plasma copolymerization. Depending on the monomer structure, polarity, type of solvent, etc. Those skilled in the art can select it in a timely manner. Of these, radical copolymerization is preferred from the viewpoint of ease of production! /, But is not limited to this! /.
[0020] また、共重合体の形態としては、ランダム共重合体、ブロック共重合体、グラフト共重 合体および交互共重合体が挙げられる。中でも製造容易性の観点力 ランダム共重 合体が好ま 、が、これに限定されるものではな 、。 [0020] Examples of the form of the copolymer include a random copolymer, a block copolymer, a graft copolymer, and an alternating copolymer. Among these, random copolymer is preferred from the viewpoint of manufacturability, but it is not limited to this.
[0021] さらに、上記共重合体における (A)と (B)との存在比(共重合比)は、共重合体の成 形カロェ性の観点から、(B)を 1とした場合、(A)は 1〜2000、好ましくは 100〜2000 であるが、これに限定されるものではない。 [0021] Further, the abundance ratio (copolymerization ratio) between (A) and (B) in the above copolymer is (1) from the viewpoint of the formation caloric property of the copolymer. A) is 1 to 2000, preferably 100 to 2000, but is not limited thereto.
[0022] 上記 (A)反応性官能基を有さな!/、含フッ素モノマーとは、上述の反応性官能基を有 さず、重合により得られる共重合体の主鎖および Zまたは側鎖の少なくとも 1つの水 素原子がフッ素に置換された共重合体が得られるものである。中でも入手が容易で あり、得られる共重合体の成形加工性の観点から、反応性官能基を有さない含フッ 素エチレン性モノマーが好ましいが、これに限定されるものではない。 [0022] The (A) fluorine-containing monomer having no reactive functional group is a main chain and a Z or side chain of a copolymer that does not have the above-mentioned reactive functional group and is obtained by polymerization. A copolymer in which at least one hydrogen atom is substituted with fluorine is obtained. Among these, a fluorine-containing ethylenic monomer having no reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
[0023] 上記 (A)反応性官能基を有さない含フッ素エチレン性モノマーとは、少なくとも 1つの フッ素原子を含むものであり、下記式(1)で表現されるモノマーが例示される。 [0023] The (A) fluorine-containing ethylenic monomer having no reactive functional group contains at least one fluorine atom, and examples thereof include a monomer represented by the following formula (1).
[0024] [化 4] [0024] [Chemical 4]
し入 2—し入 Π、 し 入 2— し 入 Π 、
Y Y
(式中の X1および X2はそれぞれ水素原子またはハロゲン原子、 Yは水素原子、フッ 素原子、炭素数 1〜5の含フッ素アルキル基または炭素数 1〜5の含フッ素ォキシァ ルキル基である) (Wherein X 1 and X 2 are each a hydrogen atom or a halogen atom, Y is a hydrogen atom, a fluorine atom, a fluorinated alkyl group having 1 to 5 carbon atoms or a fluorinated oxyalkyl group having 1 to 5 carbon atoms. )
[0025] 上記式(1)で表現されるモノマーとしては、例えば、テトラフルォロエチレン、フッ化ビ ニリデン、 1, 2—ジフノレオ口クロ口エチレン、へキサフノレオ口プロピレン、パーフノレオ口 (ビュルメチルエーテル)およびパーフルォロ(ビュルプロピルエーテル)などが挙げ られ、好ましくはテトラフルォロエチレン、フッ化ビ-リデン、 1, 2—ジフルォロクロロェ チレンおよびパーフルォロ(ビュルプロピルエーテル)などが挙げられる。中でも、入 手が容易であること、得られる共重合体の成形カ卩ェ性の観点から、テトラフルォロェ チレン、フッ化ビ-リデン、へキサフルォロプロピレンおよびパーフルォロ(ビュルプロ ピルエーテル)などが好まし 、が、これに限定されるものではな 、。 [0025] Monomers represented by the above formula (1) include, for example, tetrafluoroethylene, vinylidene fluoride, 1,2-difunoleochloroethylene, hexafluororeopropylene, perfnoreo (bulurmethyl ether). ) And perfluoro (bulupropyl ether), preferably tetrafluoroethylene, vinylidene fluoride, 1,2-difluorochloroethylene and perfluoro (bulupropyl ether). Above all, from the viewpoint of easy availability and molding cacheability of the resulting copolymer, tetrafluorobenzene. Tylene, vinylidene fluoride, hexafluoropropylene and perfluoro (bulupropyl ether) are preferred, but not limited thereto.
[0026] 一方、(B)少なくとも 1種類の反応性官能基を有する含フッ素モノマーとは、上述反 応性官能基を少なくとも 1つ有し、重合により得られる共重合体の主鎖および Zまた は側鎖の少なくとも 1つの水素原子がフッ素に置換された共重合体が得られるもので ある。中でも入手が容易であり、得られる共重合体の成形加工性の観点から、反応性 官能基を有する含フッ素エチレン性モノマーが好まし 、が、これに限定されるもので はない。 [0026] On the other hand, (B) the fluorine-containing monomer having at least one kind of reactive functional group has at least one reactive functional group described above, and the main chain of the copolymer obtained by polymerization and Z or A copolymer in which at least one hydrogen atom in the side chain is substituted with fluorine is obtained. Among these, a fluorine-containing ethylenic monomer having a reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
[0027] 上記 (B)少なくとも 1種類の反応性官能基を有する含フッ素エチレン性モノマーとは [0027] (B) Fluorine-containing ethylenic monomer having at least one reactive functional group
、式(2)で表現されるモノマーが例示される。 And a monomer represented by the formula (2).
[0028] [化 5] し[0028] [Chemical 5]
(式中の X1および X2はそれぞれ水素原子またはハロゲン原子であり、 Zはヒドロキシ ル基、カルボキシル基、シァノ基、スルホン酸基またはエポキシ基であり、 Rは炭素数 f(In the formula, X 1 and X 2 are each a hydrogen atom or a halogen atom, Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group, and R is a carbon number f.
1〜40の含フッ素アルキレン基、炭素数 1〜40の含フッ素ォキシアルキレン基または 炭素数 1〜40の少なくとも 1つのエーテル結合を有する含フッ素アルキレン基である ) A fluorinated alkylene group having 1 to 40 carbon atoms, a fluorinated oxyalkylene group having 1 to 40 carbon atoms, or a fluorinated alkylene group having at least one ether bond having 1 to 40 carbon atoms.)
[0029] 上記式(2)で表現されるモノマーとしては、例えば、パーフルオロー(4 ォキサ 5 一へキセノール)(式(4) )、パーフルオロー(1, 1ージハイドロー 6 ヘプテノール)( 式(5) )、パーフルォロ一(1, 1, 9, 9—テトラハイド口一 2, 5 ビストリフルォロメチル - 3, 6—ジォキサー 8—ノネノール)(式(6) )、パーフルオロー(4 ォキサ 5—へ キセン酸)(式(7) )、パーフルォロ—(3, 6—ジォキサ— 4—トリフルォロメチル— 7— オタテノ-トリル)(式(8) )、パーフルオロー(1, 1—ジハイド口一 3—ォキサ 4 ぺ ンテスルホン酸)(式(9) )および 1, 2 エポキシ—パーフルオロー(1, 1, 2 トリハイ ドロー 6 ペンテン)(式(10) )などのモノマーが挙げられ、好ましくは低温ヒートシ一 ル性に優れたパーフルオロー(4 ォキサ 5—へキセノール)(式(4) )、パーフルォ ロー(1, 1ージハイドロー 6 ヘプテノール)(式(5) )およびパーフルオロー(1, 1, 9 , 9—テトラハイド口一 2, 5 ビストリフルォロメチル一 3, 6 ジォキサ一 8 ノネノー ル)(式(7) )などのヒドロキシル基を有するものである力 これに限定されるものでは ない。 [0029] Examples of the monomer represented by the above formula (2) include perfluoro- (4 oxa 5 monohexenol) (formula (4)), perfluoro (1, 1-dihydro-6 heptenol) (formula (5)), Perfluoro (1, 1, 9, 9—Tetrahydride 2,5 Bistrifluoromethyl-3, 6-Dioxer 8-Nenol) (Formula (6)), Perfluoro (4-Oxa-5-hexenoic acid) (Formula (7)), perfluoro- (3,6-dioxa-4-trifluoromethyl-7-otatheno-tolyl) (formula (8)), perfluoro- (1,1-dihydride 3 Ntenosulfonic acid) (formula (9)) and 1,2 epoxy-perfluoro- (1,1,2 trihydr draw 6 pentene) (formula (10)), and the like. Perfluoro- (4-oxa 5-hexenol) (formula (4)), perfluoro (1,1-dihydro-6-heptenol) (formula (5)) and perfluoro- (1, 1, 9, 9-tetrahydride) Mouth 2,5 Bistrifluoromethyl 1,3,6 Dioxa 1 8None) (formula (7)) and other forces having a hydroxyl group The present invention is not limited to this.
[0030] [化 6] [0030] [Chemical 6]
[0031] [化 7] (5) [0031] [Chemical 7] (Five)
[0032] [化 8] [0032] [Chemical 8]
[0033] [化 9] [0033] [Chemical 9]
CF2=CF»OCF2CF2CF2»COOH (7) CF 2 = CF »OCF2CF 2 CF 2 » COOH (7)
[0034] [化 10] [0034] [Chemical 10]
CF3 (¾ CF 3 (¾
[0035] [化 11] [0035] [Chemical 11]
CH2=CF-OCF H2 -S04H (9) CH 2 = CF-OCF H 2 -S0 4 H (9)
[0036] [化 12] 丄 n 2 丄 2 H A (10) [0036] [Chemical 12] 丄 n 2 丄 2 HA (10)
o o
[0037] 本発明における接着性含フッ素高分子の好ましい形態としては、製造の容易性の観 点から、以下の式 (3)で表現される共重合体が例示されるが、これに限定されるもの ではない。 [0037] A preferred form of the adhesive fluorine-containing polymer in the present invention is exemplified by a copolymer represented by the following formula (3) from the viewpoint of ease of production, but is not limited thereto. It is not something.
[0038] [化 13] [0038] [Chemical 13]
(式中の X1および X2はそれぞれ水素原子またはハロゲン原子であり、 γ1および γ2は それぞれ水素原子、フッ素原子、炭素数 1〜5の含フッ素アルキル基または炭素数 1 〜5の含フッ素アルコキシ基であり、 zはヒドロキシル基、カルボキシル基、シァノ基、 スルホン酸基またはエポキシ基であり、 Rは炭素数 1〜40の含フッ素アルキレン基、 f (In the formula, X 1 and X 2 are each a hydrogen atom or a halogen atom, and γ 1 and γ 2 are each a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a carbon atom having 1 to 5 carbon atoms. A fluorine alkoxy group, z is a hydroxyl group, carboxyl group, cyano group, sulfonic acid group or epoxy group, R is a fluorine-containing alkylene group having 1 to 40 carbon atoms, f
炭素数 1〜40の含フッ素ォキシアルキレン基または炭素数 1〜40の少なくとも 1つの エーテル結合を有する含フッ素アルキレン基であり、 (1+m) Zn力 〜 2000である) 上記 (l+m)Znが 2000を超えると、充分な接着性が得られないおそれがある。 A fluorine-containing oxyalkylene group having 1 to 40 carbon atoms or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn force to 2000) above (l + m ) If Zn exceeds 2000, sufficient adhesion may not be obtained.
[0039] 本発明における接着性含フッ素高分子のさらに好ましい形態としては、製造の容易 性およびヒートシール強度の関連から、以下の式(11)で表現される共重合体が例示 される力 これに限定されるものではない。 [0039] As a more preferable form of the adhesive fluorine-containing polymer in the present invention, a force represented by a copolymer represented by the following formula (11) from the viewpoint of ease of production and heat seal strength: It is not limited to.
[0040] [化 14] [0040] [Chem. 14]
(式中の x1および x2はそれぞれ水素原子またはハロゲン原子であり、 γ1および γ2は それぞれ水素原子、フッ素原子、炭素数 1〜5の含フッ素アルキル基または炭素数 1(Where x 1 and x 2 are hydrogen atoms or halogen atoms, respectively, and γ 1 and γ 2 are Respectively a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or 1 carbon atom
〜5の含フッ素アルコキシ基であり、 Rは炭素数 1 ~ 5 fluorine-containing alkoxy group, R is carbon number 1
f 〜40の含フッ素アルキレン基、炭 素数 1〜40の含フッ素ォキシアルキレン基または炭素数 1〜40の少なくとも 1つのェ 一テル結合を有する含フッ素アルキレン基であり、 (1+m) Zn力 〜 2000である) [0041] 本発明における接着性含フッ素高分子の特に好ましい形態としては、モノマーの入 手の容易性、製造の容易性およびヒートシール強度の観点から、ポリテトラフルォロ エチレンおよび Zまたはパーフルォロ(ビュルプロピルエーテル)と、パーフルオロー (1, 1, 9, 9—テトラハイド口一 2, 5—ビストリフノレオロメチノレー 3, 6—ジォキサ一 8— ノネノール)との共重合体である力 これに限定されるものではない。また、その共重 合組成比は、製造の容易性の観点から、パーフルォロ—(1, 1, 9, 9—テトラハイド口 - 2, 5—ビストリフルォロメチルー 3, 6—ジォキサ一 8—ノネノール)モノマーユニット f is a fluorine-containing alkylene group having 40 to 40 carbon atoms, a fluorine-containing alkylene group having 1 to 40 carbon atoms, or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn [0041] As a particularly preferred form of the adhesive fluorine-containing polymer in the present invention, polytetrafluoropolymer is preferable from the viewpoint of easy availability of monomers, ease of production, and heat seal strength. Co-polymerization of ethylene and Z or perfluoro (bulpropyl ether) with perfluoro- (1, 1, 9, 9—tetrahydric 2,5—bistrifanololeolomethinole 3, 6—dioxa 8—nonenol) Combined force It is not limited to this. In addition, the copolymer composition ratio of perfluoro (1,1,9,9-tetrahydride mouth-2,5-bistrifluoromethyl-3,6-dioxa 1-8- Nonenol) monomer unit
1に対して、ポリテトラフルォロエチレンモノマーユニットおよび Zまたはパーフルォロ1, polytetrafluoroethylene monomer unit and Z or perfluoro
(ビュルプロピルエーテル)モノマーユニットとの合計が約 2〜2000、好ましくは約 4 〜2000である力 これに限定されるものではない。 (Bulupropyl ether) A force with the total of monomer units of about 2 to 2000, preferably about 4 to 2000, but is not limited thereto.
[0042] 本発明にお ヽて、上記接着性含フッ素高分子フィルムは、接着性部位を有する接着 性含フッ素高分子力もなるものであることが好ましい。 [0042] In the present invention, it is preferable that the adhesive fluorine-containing polymer film has an adhesive fluorine-containing polymer force having an adhesive site.
上記接着性含フッ素高分子は、接着性部位として上述の反応性官能基を有して ヽて ちょい。 The above-mentioned adhesive fluorine-containing polymer should have the above-mentioned reactive functional group as an adhesive site.
上記接着性含フッ素高分子フィルムは、後述の接着性フッ素榭脂層を形成するもの であってもよい。上記接着性含フッ素高分子は、接着性フッ素榭脂を構成するもので あってもよい。 The above-mentioned adhesive fluorine-containing polymer film may form an adhesive fluorine resin layer described later. The above-mentioned adhesive fluorine-containing polymer may constitute an adhesive fluorine resin.
[0043] 本発明における接着性フッ素榭脂層は、接着性フッ素榭脂からなるものである。 [0043] The adhesive fluorine resin layer in the present invention is made of an adhesive fluorine resin.
本明細書において、上記接着性フッ素榭脂は、接着性部位を有するフルォロポリマ 一であることが好ましい。 In the present specification, the adhesive fluorine resin is preferably a fluoropolymer having an adhesive site.
[0044] 本明細書において、上記フルォロポリマーは、含フッ素モノマーに由来する含フッ素 モノマー単位を主鎖中に有するポリマーである。上記フルォロポリマーは、更に、フッ 素非含有モノマーに由来するフッ素非含有モノマー単位を有するものであってもよ ヽ し、有しないものものであってもよい。 本明細書において、上記フルォロポリマーについての「モノマー単位」は、ポリマー分 子構造の一部分であって、モノマーに由来する部分を意味する。例えば、テトラフル ォロエチレン単位は、一(CF -CF )—で表される。 In the present specification, the fluoropolymer is a polymer having a fluorine-containing monomer unit derived from a fluorine-containing monomer in the main chain. Further, the fluoropolymer may or may not have a fluorine-free monomer unit derived from a fluorine-free monomer. In the present specification, the “monomer unit” for the fluoropolymer means a part of a polymer molecular structure derived from a monomer. For example, a tetrafluoroethylene unit is represented by one (CF 3 -CF 3) —.
2 2 twenty two
[0045] 上記含フッ素モノマーは、フッ素原子を有する重合可能な化合物であれば特に限定 されず、例えば、テトラフルォロエチレン〔TFE〕、フッ化ビ-リデン〔VdF〕、クロ口トリ フルォロエチレン〔CTFE〕、フッ化ビニル〔VF〕、へキサフルォロプロピレン〔HFP〕、 へキサフルォロイソブテン、パーフルォロ(アルキルビュルエーテル)〔PAVE〕類、下 記一般式 (i) : [0045] The fluorine-containing monomer is not particularly limited as long as it is a polymerizable compound having a fluorine atom, and examples thereof include tetrafluoroethylene [TFE], vinylidene fluoride [VdF], black trifluoroethylene [ CTFE], vinyl fluoride [VF], hexafluoropropylene [HFP], hexafluoroisobutene, perfluoro (alkyl butyl ether) [PAVE] s, the following general formula (i):
CH =CX3 (CF ) X4 (i) CH = CX 3 (CF) X 4 (i)
2 2 n 2 2 n
(式中、 x3は、水素原子又はフッ素原子を表し、 X4は、水素原子、フッ素原子又は塩 素原子を表し、 nは、 1〜10の整数を表す。)で表されるモノマー等が挙げられる。 (Wherein x 3 represents a hydrogen atom or a fluorine atom, X 4 represents a hydrogen atom, a fluorine atom or a chlorine atom, and n represents an integer of 1 to 10), etc. Is mentioned.
[0046] 上記フッ素非含有モノマーは、上記含フッ素モノマーと共重合可能でフッ素原子を 有さない化合物であれば特に限定されず、例えば、エチレン〔Et〕、プロピレン、 1 ブテン、 2—ブテン、塩化ビニル、塩化ビ-リデン等が挙げられる。 [0046] The fluorine-free monomer is not particularly limited as long as it is a compound copolymerizable with the fluorine-containing monomer and does not have a fluorine atom. For example, ethylene [Et], propylene, 1-butene, 2-butene, Examples include vinyl chloride and vinylidene chloride.
[0047] 上記フルォロポリマーとしては、下記共重合体 (I)、下記共重合体 (Π)等が挙げられ る。 [0047] Examples of the fluoropolymer include the following copolymer (I) and the following copolymer (Π).
(I)少なくとも、 TFE及び Etを重合してなる共重合体、 (I) a copolymer obtained by polymerizing at least TFE and Et,
(Π)少なくとも、 TFEと、下記一般式 (ii) (Ii) At least TFE and the following general formula (ii)
CF =CF-R 2 (ii) CF = CF-R 2 (ii)
2 f 2 f
(式中、 R 2は、 CF又は— OR 1を表し、 R 1は、炭素数 1〜5のパーフルォロアルキ f 3 f f (Wherein R 2 represents CF or —OR 1 , and R 1 represents a perfluoroalkyl having 3 to 5 carbon atoms, f 3 ff
ル基を表す。 )で表される少なくとも 1種以上のモノマーとを重合してなる共重合体。 Represents a ru group. A copolymer obtained by polymerizing at least one monomer represented by
[0048] 上記共重合体(I)としては、例えば、少なくとも、 TFE単位 20〜80モル%及び Et単 位 80〜20モル%力もなる共重合体等が挙げられる。 [0048] Examples of the copolymer (I) include at least a copolymer having a TFE unit of 20 to 80 mol% and an Et unit of 80 to 20 mol%.
本明細書において、各モノマー単位についてのモル%は、共重合体の分子鎖を構 成するモノマー単位が由来することとなったモノマーの合計モル数のうち、後述する 接着性部位含有モノマー単位が由来することとなったモノマーのモル数を除いたモ ル数を 100モル0 /0とし、この 100モル0 /0中に占める各モノマー単位が由来することと なったモノマーのモル数の割合である。 上記各モノマー単位についてのモル%は、 F— NMRチャートから求めた値である In the present specification, the mol% for each monomer unit is the adhesive site-containing monomer unit described later, out of the total number of moles of the monomer from which the monomer unit constituting the molecular chain of the copolymer is derived. the model number Le excluding moles of monomer was decided that derived as 100 mole 0/0, a ratio of moles of monomer each monomer unit was to derived occupied in the 100 mole 0/0 is there. The mol% for each monomer unit is a value obtained from an F-NMR chart.
[0049] 上記共重合体 (I)は、主鎖中に、 TFE単位と Et単位以外に、共重合可能なその他の モノマーに由来するその他のモノマー単位を有するものであってもよぐ上記その他 のモノマーとして、得られる積層フィルムの用途に応じた種類のモノマーを適宜選択 して共重合に供することができる。 [0049] The copolymer (I) may have other monomer units derived from other copolymerizable monomers in addition to the TFE unit and Et unit in the main chain. As the monomer, a monomer of a type corresponding to the use of the obtained laminated film can be appropriately selected and used for copolymerization.
上記その他のモノマーとしては、 HFP、 CTFE、プロピレン、下記一般式(iii): CX5 =CX6 (CF ) X7 (iii) Examples of other monomers include HFP, CTFE, propylene, and the following general formula (iii): CX 5 = CX 6 (CF) X 7 (iii)
2 2 n 2 2 n
(式中、 X5及び X6は、同一又は異なって、水素原子若しくはフッ素原子を表し、 X7は 、水素原子、フッ素原子又は塩素原子を表し、 nは、 1〜10の整数を表す。)で表され るモノマー、下記一般式 (iv) : (In the formula, X 5 and X 6 are the same or different and each represents a hydrogen atom or a fluorine atom; X 7 represents a hydrogen atom, a fluorine atom or a chlorine atom; and n represents an integer of 1 to 10. ) Monomers represented by the following general formula (iv):
CF =CF— OR 1 (iv) CF = CF— OR 1 (iv)
2 f 2 f
(式中、 R 1は、炭素数 1〜5のパーフルォロアルキル基を表す。)で表されるモノマー f (Wherein R 1 represents a perfluoroalkyl group having 1 to 5 carbon atoms) f
等が挙げられ、通常これらの 1種又は 2種以上が用いられる。 In general, one or more of these are used.
上記その他のモノマー単位は、共重合体 (I)の分子鎖を構成するモノマー単位 100 モル0 /0のうち 0〜 20モル0 /0の割合で有するものであつてもよい。 These and other monomer units may be filed those having a ratio of 0-20 mole 0/0 of the monomeric units 100 mole 0/0 constituting the molecular chain of the copolymer (I).
[0050] 上記フルォロポリマーとしては、耐熱性、耐薬品性、耐候性、電気絶縁性、薬液低透 過性、非粘着性等に優れている点で、共重合体 (I)が好ましぐ耐熱性、耐薬品性、 耐候性、電気絶縁性、薬液低透過性、非粘着性、低温加工性、透明性等に優れて いる点で、 EtZTFEZHFP共重合体がより好ましい。上記 EtZTFEZHFP共重合 体における HFP単位は、 5〜20モル%であることが好ましぐより好ましい下限が 8モ ル%であり、より好ましい上限が 17モル%である。上記 EtZTFEZHFP共重合体は 、 Et、 TFE及び HFPに由来する各モノマー単位に加え、上記 EtZTFEZHFP共 重合体の好まし 、性質を損なわな 、範囲で、 HFP単位以外の上記その他のモノマ 一を 1種又は 2種以上有するものであってもよ 、。 [0050] As the above fluoropolymer, copolymer (I) is preferred in terms of heat resistance, chemical resistance, weather resistance, electrical insulation, low liquid chemical permeability, non-adhesiveness, etc. EtZTFEZHFP copolymer is more preferable because of its excellent properties, chemical resistance, weather resistance, electrical insulation, low chemical permeability, non-adhesiveness, low-temperature processability, transparency and the like. The HFP unit in the above EtZTFEZHFP copolymer preferably has a lower limit of 8 mol%, more preferably 5 to 20 mol%, and a more preferable upper limit of 17 mol%. In addition to the monomer units derived from Et, TFE, and HFP, the EtZTFEZHFP copolymer is one kind of the above-mentioned other monomers other than the HFP unit, as long as the EtZTFEZHFP copolymer is preferred and does not lose its properties. Or you may have two or more.
[0051] 本明細書にぉ 、て、上記「接着性部位」とは、ポリイミド〔PI〕フィルム等の上述した有 機材料との親和性若しくは反応性を有する官能基を意味する。 In the present specification, the “adhesive site” means a functional group having affinity or reactivity with the above-mentioned organic material such as polyimide [PI] film.
本明細書において、「親和性」とは、水素結合、 van der Waals力等、化学構造を 変化させるまでに至らない PIフィルム等の有機材料との相互作用を示す性質を意味 し、「反応性」とは、官能基等の化学構造を変化させる性質を意味する。 In this specification, “affinity” means a chemical structure such as hydrogen bond, van der Waals force, etc. It means a property that shows an interaction with an organic material such as a PI film that does not lead to a change, and “reactivity” means a property that changes a chemical structure such as a functional group.
[0052] 上記接着性部位は、通常、上記フルォロポリマーが主鎖又は側鎖に有するものであ る。 [0052] The adhesive site is usually one that the fluoropolymer has in the main chain or side chain.
上記接着性部位としては、特に限定されないが、例えば、炭素 炭素二重結合、力 ルポニル基 [-C ( =〇)]、カルボ-ル基を有する基又は結合等が挙げられ、上記接 着性部位を有するフルォロポリマーにお 、て、上記接着性部位は 1種のみ存在する ものであってもよ 、し、 2種以上存在するものであってもよ!/、。 The adhesive site is not particularly limited, and examples thereof include a carbon-carbon double bond, a force sulfonyl group [-C (= O)], a group having a carbo group or a bond, and the like. In the fluoropolymer having a site, there may be only one type of adhesive site, or two or more types of adhesive sites! /.
上記「接着性部位」としては、上述の反応性官能基であってもよ 、。 The “adhesive site” may be the reactive functional group described above.
[0053] 上記カルボ二ル基を有する基又は結合としては、例えば、カーボネート基、ハロゲノ ホルミル基、ホルミル基、カルボキシル基、カルボ-ルォキシ基 [ C ( = o) o ]、酸 無水物基 [― C ( = 0) 0— C ( = 0)— ]、イソシァネート基、アミド基 [― C ( = 0)—N H ]、イミド基 [― C ( = 0)— NH— C ( = 0)— ]、ウレタン結合 [― NH— C ( = 0) 0 ]、力ルバモイル基 [NH—C ( = 0)—]、力ルバモイルォキシ基 [NH—C ( = 0) [0053] Examples of the group or bond having a carbonyl group include a carbonate group, a halogenoformyl group, a formyl group, a carboxyl group, a carbo-loxy group [C (= o) o], an acid anhydride group [- C (= 0) 0— C (= 0) —], isocyanate group, amide group [— C (= 0) —NH], imide group [— C (= 0) — NH— C (= 0) —] , Urethane bond [― NH— C (= 0) 0], force rumomoyl group [NH—C (= 0) —], force rumomoyloxy group [NH—C (= 0)
2 2 twenty two
O ]、ウレイド基 [NH― C ( = 0)— NH ]、ォキサモイル基 [NH― C ( = 0)— C O], ureido group [NH—C (= 0) —NH], oxamoyl group [NH—C (= 0) —C
2 2 twenty two
(=o)—]等が挙げられる。 (= o) —] and the like.
上記カルボ二ル基を有する基又は結合としては、導入が容易であり、反応性が高い 点から、カーボネート基、ハロゲノホルミル基等が好ましい。 The group or bond having a carbonyl group is preferably a carbonate group, a halogenoformyl group or the like from the viewpoint of easy introduction and high reactivity.
[0054] 上記カーボネート基は、 [― OC ( = 0) 0 ]で表される結合を有する基であり、― O C ( = 0) 0— R基 (式中、 Rは、有機基、 IA族原子、 ΠΑ族原子、又は、 VIIB族原子 を表す。)で表されるものである。上記式中の Rにおける有機基としては、例えば炭素 数 1〜20のアルキル基、エーテル結合を構成する酸素分子を有する炭素数 2〜20 のアルキル基等が挙げられ、好ましくは炭素数 1〜8のアルキル基、エーテル結合を 構成する酸素分子を有する炭素数 2〜4のアルキル基等である。上記カーボネート基 としては、例えば、一 OC ( = 0) 0— CH 、 一 OC ( = 0) 0— C H 、 一 OC ( = 0) 0 [0054] The carbonate group is a group having a bond represented by [-OC (= 0) 0],-OC (= 0) 0- R group (wherein R is an organic group, group IA Represents an atom, a group IV atom, or a group VIIB atom.) Examples of the organic group for R in the above formula include an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms having an oxygen molecule constituting an ether bond, and preferably 1 to 8 carbon atoms. Or an alkyl group having 2 to 4 carbon atoms and having an oxygen molecule constituting an ether bond. Examples of the carbonate group include one OC (= 0) 0—CH, one OC (= 0) 0—C H, one OC (= 0) 0
3 3 7 3 3 7
― C H 、― OC ( = 0) 0— CH CH OCH CH等が挙げられる。 —CH, —OC (= 0) 0—CH CH OCH CH and the like.
8 17 2 2 2 3 8 17 2 2 2 3
[0055] 上記ハロゲノホルミル基は、 COY (式中、 Yは、 VIIB族原子を表す。 )で表されるも のであり、― COF、― COC1等が好ましい。 [0056] 上記接着性部位の数は、基材の種類、形状、用途、必要とされる接着強度、上述の フルォロポリマーの種類の違い等により適宜選択されうるが、通常、主鎖炭素数 1 X 1 06個あたり 3〜: LOOO個である。上記接着性部位の数は、カルボニル基の数をカウン トする場合、通常、主鎖炭素数 1 X 106個あたり 150個以上であり、好ましくは 250個 以上、より好ましくは 300個以上である。 [0055] The halogenoformyl group is represented by COY (wherein Y represents a VIIB group atom), and -COF, -COC1, and the like are preferable. [0056] The number of the adhesive sites may be appropriately selected depending on the type, shape, application, required adhesive strength, difference in the type of the fluoropolymer, and the like. 10 per 6 3 ~: LOOO. When counting the number of carbonyl groups, the number of the above-mentioned adhesive sites is usually 150 or more, preferably 250 or more, more preferably 300 or more per 1 × 10 6 main chain carbon atoms. .
本明細書において、上記「接着性部位」の数は、国際公開 99Z45044号パンフレツ トに記載のカルボニル基含有官能基の個数の測定方法に準じた赤外吸収スペクトル 分析を行うことにより測定したものである。 In the present specification, the number of the “adhesive sites” is measured by performing an infrared absorption spectrum analysis in accordance with the method for measuring the number of carbonyl group-containing functional groups described in International Publication No. 99Z45044. is there.
[0057] 上記接着性フッ素榭脂としては、例えば、国際公開 99Z45044号パンフレットに記 載のカルボニル基含有官能基を有する含フッ素エチレン性重合体等を挙げることが できる。 [0057] Examples of the adhesive fluorine resin include a fluorine-containing ethylenic polymer having a carbonyl group-containing functional group described in International Publication No. 99Z45044 pamphlet.
上記接着性フッ素榭脂は、通常、重合によりフルォロポリマーを製造するに際し接着 性部位を導入することにより得ることができるが、接着性部位を導入する方法としては 特に限定されず、例えば、(1)接着性部位含有モノマーを共重合する方法、(2)接 着性部位を有する重合開始剤を存在させて乳化重合等の水性媒体中での重合を行 い、ポリマー鎖末端に該重合開始剤に由来する接着性部位を導入する方法、(3)重 合に際し又は重合後の加熱等によりポリマー鎖中の炭素 炭素単結合が二重結合 に変化することにより接着性部位を有することとなる方法等が挙げられる。 The adhesive fluorine resin can be usually obtained by introducing an adhesive site in the production of a fluoropolymer by polymerization, but the method for introducing the adhesive site is not particularly limited. For example, (1) A method of copolymerizing a monomer containing an adhesive moiety, (2) polymerization in an aqueous medium such as emulsion polymerization in the presence of a polymerization initiator having an adhesive moiety, and the polymerization initiator at the end of the polymer chain (3) A method in which the carbon-carbon single bond in the polymer chain is changed to a double bond during polymerization or by heating after polymerization, etc. Is mentioned.
[0058] 上記(1)の方法は、例えば、接着性部位含有モノマーを、目的の接着性フッ素榭脂 に応じた種類と配合の含フッ素モノマーと、所望によりフッ素非含有モノマーとを公知 の方法により共重合させることによって行うことができる。 [0058] In the method of (1), for example, an adhesive site-containing monomer, a fluorine-containing monomer of a type and a composition depending on the target adhesive fluorine resin, and optionally a fluorine-free monomer are known. Can be carried out by copolymerization.
上記共重合の方法としては特に限定されず、例えば、含フッ素モノマー等の他の共 単量体によるポリマー鎖形成時に接着性部位含有モノマーを系内に導入して行うラ ンダム共重合であってもよいし、ブロック共重合、グラフト共重合であってもよい。ダラ フト共重合としては、例えば、フルォロポリマーに後述の不飽和カルボン酸類を付カロ させる方法等が挙げられる。 The copolymerization method is not particularly limited, and is, for example, random copolymerization in which an adhesive site-containing monomer is introduced into the system when a polymer chain is formed with another comonomer such as a fluorine-containing monomer. Alternatively, block copolymerization or graft copolymerization may be used. Examples of the draft copolymerization include a method in which an unsaturated carboxylic acid described later is attached to a fluoropolymer.
[0059] 上記「接着性部位含有モノマー」とは、接着性部位を有する重合可能な化合物を意 味し、フッ素原子を有していてもよいし、有していなくてもよい。なお、本明細書にお いて、上述した「含フッ素モノマー」及び「フッ素非含有モノマー」は、上記接着性部 位を有して ヽな 、ものである。 [0059] The "adhesive moiety-containing monomer" means a polymerizable compound having an adhesive moiety, and may or may not have a fluorine atom. In this specification, The above-mentioned “fluorine-containing monomer” and “fluorine-free monomer” are those having the above-mentioned adhesive part.
[0060] 上記接着性部位含有モノマーとしては、例えば、接着性部位がカルボ-ル基を有す る基又は結合である場合、パーフルォロアクリル酸フルオライド、 1 フルォロアクリル 酸フルオライド、アクリル酸フルオライド、 1 トリフルォロメタクリル酸フルオライド、ノ 一フルォロブテン酸等のフッ素を有するモノマー;アクリル酸、メタクリル酸、アクリル 酸クロライド、ビ-レンカーボネート等のフッ素を有さな 、モノマーが挙げられる。 [0060] Examples of the adhesive part-containing monomer include, when the adhesive part is a group having a carbo group or a bond, perfluoroacrylic acid fluoride, 1 fluoroacrylic acid fluoride, acrylic acid fluoride, 1 Monomers having fluorine such as trifluoromethacrylic acid fluoride and monofluorobutenoic acid; monomers having no fluorine such as acrylic acid, methacrylic acid, acrylic acid chloride and beylene carbonate.
[0061] 上記接着性部位含有モノマーとしては、更に、不飽和カルボン酸類が挙げられる。 [0061] Examples of the adhesive site-containing monomer further include unsaturated carboxylic acids.
本明細書において、上記不飽和カルボン酸類とは、共重合を可能にする炭素 炭 素不飽和結合 (以下、「共重合性炭素 炭素不飽和結合」ともいう。)を 1分子中に少 なくとも 1個有し、且つ、カルボ-ルォキシ基 [― C ( = 0)— O ]を 1分子中に少なく とも 1個有する化合物であればよぐなかでも、上記共重合性炭素 炭素不飽和結 合が 1分子中に 1個であるものが好まし!/、。 In the present specification, the above unsaturated carboxylic acids means at least a carbon-carbon unsaturated bond (hereinafter also referred to as “copolymerizable carbon-carbon unsaturated bond”) that enables copolymerization in at least one molecule. Even if it is a compound having one and having at least one carbo-loxy group [—C (= 0) —O] in one molecule, the above-mentioned copolymerizable carbon-carbon unsaturated bond Is preferred to have 1 per molecule! /.
上記不飽和カルボン酸類としては、例えば、脂肪族不飽和カルボン酸及びその酸無 水物が挙げられる。上記脂肪族不飽和カルボン酸としては、脂肪族不飽和モノカル ボン酸であってもよ!/、し、カルボキシル基を 2個以上有する脂肪族不飽和ポリカルボ ン酸であってもよい。 Examples of the unsaturated carboxylic acids include aliphatic unsaturated carboxylic acids and acid anhydrides thereof. The aliphatic unsaturated carboxylic acid may be an aliphatic unsaturated monocarboxylic acid, or may be an aliphatic unsaturated polycarboxylic acid having two or more carboxyl groups.
上記脂肪族不飽和モノカルボン酸としては、例えば、プロピオン酸、アクリル酸、メタ クリル酸、クロトン酸、それらの酸無水物等、炭素数 3〜20の脂肪族モノカルボン酸 等が挙げられる。上記脂肪族不飽和ポリカルボン酸としては、マレイン酸、フマル酸、 メサコン酸、シトラコン酸〔CAC〕、ィタコン酸、アコニット酸、無水ィタコン酸〔IAH〕及 び無水シトラコン酸〔CAH〕等が挙げられる。 As said aliphatic unsaturated monocarboxylic acid, C3-C20 aliphatic monocarboxylic acid etc., such as propionic acid, acrylic acid, methacrylic acid, crotonic acid, those acid anhydrides, etc. are mentioned, for example. Examples of the aliphatic unsaturated polycarboxylic acid include maleic acid, fumaric acid, mesaconic acid, citraconic acid [CAC], itaconic acid, aconitic acid, itaconic anhydride [IAH], and citraconic anhydride [CAH]. .
[0062] 上記(2)の方法における重合開始剤としては、ジイソプロピルパーォキシカーボネー ト、ジ—n—プロピルパーォキシジカーボネート、 t ブチルパーォキシイソプロピル力 ーボネート、ビス(4— tーブチルシクロへキシル)パーォキシジカーボネート、ジ 2 ーェチルへキシルバーォキシジカーボネート等が挙げられる。 [0062] As the polymerization initiator in the above method (2), diisopropyl peroxy carbonate, di-n-propyl peroxydicarbonate, t-butyl peroxy isopropyl carbonate, bis (4-tert-butyl cyclohexane) are used. Hexyl) peroxydicarbonate, di-2-ethylhexyloxydicarbonate and the like.
[0063] 上記接着性フッ素榭脂は、得られる積層フィルムのシール性の点で、融点が好ましく は 200°C以下であり、より好ましくは 180°C以下である。 本明細書において、上記融点は、示差走査熱量計 (セイコー社製)を用い、昇温速 度 10°CZ分にて測定し、得られた融解ピークの極大値での温度である。 [0063] The adhesive fluorine resin has a melting point of preferably 200 ° C or lower, more preferably 180 ° C or lower, from the viewpoint of the sealing property of the obtained laminated film. In the present specification, the melting point is a temperature at the maximum value of the melting peak obtained by measuring with a differential scanning calorimeter (Seiko Co., Ltd.) at a heating rate of 10 ° CZ.
[0064] 本発明における接着性含フッ素高分子フィルムは、さらに該接着性含フッ素高分子 フィルム以外のフィルムとの積層フィルムの形態であってもよ 、。本発明における積 層フィルムとは、少なくとも接着性含フッ素高分子フィルムと、該接着性含フッ素高分 子フィルム以外のフィルムを積層し、該接着性含フッ素高分子フィルムが少なくとも片 方の最外面に存在するものであればよい。その層数は、 2層以上であればよいが、内 容物への熱伝導度の観点から、 2〜5層、好ましくは 2および 3層である力 これに限 定されるものではない。 [0064] The adhesive fluorine-containing polymer film in the present invention may be in the form of a laminated film with a film other than the adhesive fluorine-containing polymer film. The laminated film in the present invention is a laminate of at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, and the adhesive fluorine-containing polymer film is at least one outermost surface. As long as it exists in The number of layers may be two or more, but from the viewpoint of thermal conductivity to the contents, the force is 2 to 5 layers, preferably 2 and 3 layers, but is not limited thereto.
[0065] また、積層フィルムの膜厚は層数に依存するが、例えば接着性含フッ素高分子フィ ルム以外のフィルムの片面に設けた接着性含フッ素高分子フィルムの 2層フィルムで ある場合、内容物への熱伝導度の観点から、全体の膜厚が約20〜200 111、好まし くは約 20〜: LOO μ m、特に好ましくは約 20〜60 μ mであるが、これらに限定されるも のではない。 [0065] The film thickness of the laminated film depends on the number of layers. For example, when the film is a two-layer film of an adhesive fluorine-containing polymer film provided on one side of the film other than the adhesive fluorine-containing polymer film, From the viewpoint of thermal conductivity to the contents, the total film thickness is about 20 to 200 111, preferably about 20 to: LOO μm, particularly preferably about 20 to 60 μm, but is not limited thereto. It is not done.
[0066] また、上記接着性フッ素榭脂層の厚さは、 5〜: LOO /z mであることが好ましいが、 10 μ m以上、 50 μ m以下であることがより好ましい。 [0066] The thickness of the adhesive fluorine resin layer is preferably 5 to: LOO / zm, more preferably 10 µm or more and 50 µm or less.
[0067] 本発明における積層フィルムは、上述の熱ラミネーシヨン法により作成した場合、接 着強度 (X)を、一般に 200NZm以上、好ましくは 300NZm以上、より好ましくは 40[0067] When the laminated film of the present invention is produced by the above-mentioned thermal lamination method, the adhesion strength (X) is generally 200 NZm or more, preferably 300 NZm or more, more preferably 40.
ONZm以上にすることができる。 It can be over ONZm.
本明細書において、上記接着強度 (X)は、積層フィルムを 10mm幅に切り出し、その 端の接着性フッ素榭脂層と PIフィルム等の接着性含フッ素高分子フィルム以外のフィ ルムとを刃物を用いて剥離し掴みしろを作り、テンシロン万能試験機にて、 25mmZ 分の速度で 180° 剥離させた時に要した強度である。 In the present specification, the adhesive strength (X) is obtained by cutting a laminated film into a width of 10 mm, and using an edge of an adhesive fluororesin layer at the end and a film other than an adhesive fluorine-containing polymer film such as a PI film. This is the strength required when peeled off to make a grip and peeled 180 ° at a speed of 25 mmZ on a Tensilon universal testing machine.
[0068] 上記接着性含フッ素高分子フィルム以外のフィルムとは、上記接着性含フッ素高分 子力 なるフィルムでなければ特に限定されるものではな 、が、耐寒性榭脂であるこ とが好ましい。 [0068] A film other than the above-mentioned adhesive fluorine-containing polymer film is not particularly limited unless it is a film having the above-mentioned adhesive fluorine-containing polymer power, but is preferably a cold-resistant resin. .
[0069] 上記耐寒性榭脂とは、約— 40度以下、好ましくは約— 80度以下において、耐衝撃 性に優れた榭脂をいう。例えば、超高分子量ポリエチレン、ポリイミド、ポリテトラフル ォロエチレン、エチレンーテトラフルォロエチレン共重合体およびエチレン 酢酸ビ ニル共重合体などが挙げられ、内容物への熱伝導度および耐寒性の観点から、ポリ イミド、ポリテトラフルォロエチレンおよびエチレンーテトラフルォロエチレン共重合体 が好ましぐより好ましくはポリイミドである。また耐寒性榭脂の分子量は、成形加工性 の観点力も、数平均分子量で約 1, 000〜1, 000, 000、好まし <は約 2, 000〜50 0, 000、さらに好まし <ίま約 5, 000〜300, 000である力 これらに限定されるちので はない。 [0069] The cold-resistant rosin refers to a rosin excellent in impact resistance at about -40 degrees or less, preferably about -80 degrees or less. For example, ultra high molecular weight polyethylene, polyimide, polytetraflur Examples include fluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene vinyl acetate copolymer. From the viewpoint of thermal conductivity to the contents and cold resistance, polyimide, polytetrafluoroethylene, and ethylene Polytetrafluoroethylene copolymer is more preferable than polyimide. In addition, the molecular weight of cold-resistant rosin has a number average molecular weight of about 1,000 to 1,000,000, preferably <2,000 to 500,000, more preferably < The force that is about 5,000-300,000 is not limited to these.
上記耐衝撃性は、凍結環境下から取り出した直後の榭脂フィルム又は榭脂シートに ついて、自由落下のダート法による衝撃試験方法 (ステアケース法 (JIS Κ 7124- 1) )を用いて評価するものである。上記耐衝撃性に優れた榭脂としては、上記ステア ケース法 (液体窒素温度)における 50%破壊エネルギー (Ε50)が 0. 1以上、好まし くは 0. 2以上、更に好ましくは 1. 0以上であるものが好ましい。 The above impact resistance is evaluated using a free fall dart impact test method (staircase method (JIS Κ 7124-1)) for a resin film or sheet immediately after removal from a frozen environment. Is. As the above-mentioned resin having excellent impact resistance, the 50% fracture energy (Ε50) in the above-mentioned staircase method (liquid nitrogen temperature) is 0.1 or more, preferably 0.2 or more, more preferably 1.0. The above is preferable.
[0070] 上記ポリイミドは、主鎖にイミド結合を有する耐熱性の高分子力もなるものであればよ ぐ例えば、主鎖にイミド結合のみを有する非熱可塑性ポリイミド、全芳香族ポリイミド 、有機溶媒可溶性ポリイミド、ポリエーテルイミドおよびポリイミドアミドなどが挙げられ る力 これに限定されるものではない。 [0070] The polyimide is not particularly limited as long as it has a heat-resistant polymer force having an imide bond in the main chain, for example, a non-thermoplastic polyimide having only an imide bond in the main chain, a wholly aromatic polyimide, an organic solvent soluble Forces including, but not limited to, polyimide, polyetherimide, and polyimideamide.
[0071] また、上記耐寒性榭脂フィルムは、例えば、耐寒性榭脂を高温高圧における熱溶融 法、押出法または圧縮法および溶剤キャスティング法などにより成形されたものが挙 げられる力 これに限定されるものではない。 [0071] In addition, the cold-resistant resin film includes, for example, a force obtained by forming a cold-resistant resin by a hot melting method, an extrusion method or a compression method and a solvent casting method at a high temperature and a high pressure. Is not to be done.
[0072] 上記積層フィルムにおける接着性含フッ素高分子フィルムと、接着性含フッ素高分子 フィルム以外のフィルムとの積層は、熱ラミネート法や熱圧縮法および高周波加熱法 および溶剤キャスティング法などが挙げられる。中でも製造の容易性の観点から熱ラ ミネート法が好ましいが、これに限定されるものではない。接着性含フッ素高分子フィ ルムが上記接着性含フッ素高分子フィルム以外のフィルムと強固に接着するため、 接着性含フッ素高分子フィルム以外のフィルムとから接着性含フッ素高分子フィルム が剥がれることがない。上記熱ラミネート法における温度条件は、製造における安全 性などの観点から、約 200〜300°C、好ましくは約 200〜250°Cである力 これに限 定されるものではない。 [0073] 本発明における積層フィルムは、上述の PIフィルム等の接着性含フッ素高分子フィ ルム以外のフィルムと接着性フッ素榭脂とを積層することにより作成することができる 上記 PIフィルム等の接着性含フッ素高分子フィルム以外のフィルムと接着性フッ素榭 脂との積層は、例えば、押出ラミネーシヨン法にて行うことができるし、 PIフィルム等の 接着性含フッ素高分子フィルム以外のフィルムと接着性フッ素榭脂とを熱圧着等によ り貼り合わせて行うこともできる。 [0072] Examples of the lamination of the adhesive fluorine-containing polymer film and the film other than the adhesive fluorine-containing polymer film in the laminated film include a heat laminating method, a heat compression method, a high-frequency heating method, and a solvent casting method. . Of these, the thermal lamination method is preferable from the viewpoint of ease of production, but is not limited thereto. Since the adhesive fluorine-containing polymer film adheres firmly to a film other than the above-mentioned adhesive fluorine-containing polymer film, the adhesive fluorine-containing polymer film may be peeled off from the film other than the adhesive fluorine-containing polymer film. Absent. The temperature condition in the thermal laminating method is a force of about 200 to 300 ° C., preferably about 200 to 250 ° C., from the viewpoint of safety in production and the like, but is not limited thereto. [0073] The laminated film in the present invention can be prepared by laminating a film other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film and an adhesive fluorine resin. Laminating of a film other than the adhesive fluorine-containing polymer film and the adhesive fluorine resin can be performed, for example, by an extrusion lamination method, or bonding with a film other than the adhesive fluorine-containing polymer film such as a PI film. It is also possible to carry out by adhering a functional fluorine resin by thermocompression bonding or the like.
[0074] 上記押出ラミネーシヨンは、例えば、上述の接着性フッ素榭脂を溶融させて、上述の PIフィルム等の接着性含フッ素高分子フィルム以外のフィルム上に押し出す押出ェ 程 (a)、 PIフィルム等の接着性含フッ素高分子フィルム以外のフィルムと、押し出した 接着性フッ素榭脂とをロールで挟んで圧着する圧着工程 (b)、得られた積層物を卷 取る卷取工程 (c)等をも含むものであってよぐ通常、押出工程 (a)、圧着工程 (b)、 卷取工程 (c)の順で行う。 [0074] In the extrusion lamination, for example, an extrusion process (a) in which the above-mentioned adhesive fluorine resin is melted and extruded onto a film other than the above-mentioned adhesive fluorine-containing polymer film such as the above-mentioned PI film (a), PI A crimping step (b) of crimping a film other than an adhesive fluorine-containing polymer film, such as a film, and an extruded adhesive fluororesin sandwiched between rolls, and a scraping step of scraping the resulting laminate (c) In general, the extrusion process (a), the crimping process (b), and the scraping process (c) are performed in this order.
[0075] 上記押出工程 (a)における押出温度は、使用する PIフィルム等の接着性含フッ素高 分子フィルム以外のフィルム及び接着性フッ素榭脂の種類、 目的とする積層フィルム の厚さ等に応じて、好ましい範囲が異なる力 層間接着強度が大きい積層フィルムが 得られる点で、通常、使用する接着性フッ素榭脂の融点以上、分解温度未満である ことが好ましい。 [0075] The extrusion temperature in the extrusion step (a) depends on the type of film other than the adhesive fluorine-containing high molecular film such as the PI film used and the adhesive fluorine resin, the thickness of the target laminated film, etc. In general, it is preferably at least the melting point of the adhesive fluororesin used and less than the decomposition temperature in that a laminated film having a high interlayer adhesive strength can be obtained.
[0076] 上記押出工程 (a)にお ヽて、溶融させた接着性フッ素榭脂を上記 PIフィルム等の接 着性含フッ素高分子フィルム以外のフィルム上に押し出す速度は、使用する上記接 着性フッ素榭脂ゃ上記 PIフィルム等の接着性含フッ素高分子フィルム以外のフィル ムの組成、厚さ等によって適宜設定することができる力 例えば、 0. 1〜: LOOmZ分 の範囲で行うことができる。 [0076] In the extrusion step (a), the molten adhesive fluorine resin is extruded onto a film other than the adhesive fluorine-containing polymer film such as the PI film. A force that can be appropriately set depending on the composition, thickness, etc. of the film other than the above-mentioned adhesive fluorine-containing polymer film such as the PI film. For example, 0.1 to: LOOmZ it can.
[0077] 上記押出ラミネーシヨン、なかでも、上記押出工程 (a)は、層間接着強度が大きい積 層フィルムが得られる点で、不活性ガス中で行うこと及び Z又は PIフィルム等の接着 性含フッ素高分子フィルム以外のフィルムを予め乾燥若しくは予熱することにより水 分を除去しておくことが好ま 、。 [0077] The extrusion lamination, particularly the extrusion step (a), is performed in an inert gas and includes an adhesive property such as a Z or PI film in that a laminated film having a high interlayer adhesive strength is obtained. It is preferable to remove water by drying or preheating a film other than the fluoropolymer film in advance.
本発明において、押出ラミネーシヨンは、押出工程により接着性フッ素榭脂に存在す る接着性部位の接着性が発揮されることに特徴があると考えられるが、上記押出ラミ ネーシヨンを不活性ガス中で行う場合及び Z又は PIフィルム等の接着性含フッ素高 分子フィルム以外のフィルムを予め乾燥若しくは予熱することにより水分を除去して おく場合、上記接着性を充分に発揮することができると考えられる。 In the present invention, the extrusion lamination is present in the adhesive fluorocarbon resin by the extrusion process. However, it is considered that the above-mentioned extrusion lamination is performed in an inert gas, and a film other than an adhesive fluorine-containing high molecular film such as a Z or PI film. It is considered that the above adhesiveness can be sufficiently exhibited when moisture is removed by drying or preheating the material in advance.
[0078] 上記押出ラミネーシヨンにおける上記押出工程 (a)以外の各工程条件は、使用する P Iフィルム等の接着性含フッ素高分子フィルム以外のフィルム及び接着性フッ素榭脂 の各種類、 目的とする積層フィルムの厚さ等に応じ、公知の方法に従って適宜設定 することができる。 [0078] The process conditions other than the above-described extrusion step (a) in the above-mentioned extrusion lamination are the types of films other than the adhesive fluorine-containing polymer film such as the PI film to be used, and the types of adhesive fluorine resin. Depending on the thickness of the laminated film, etc., it can be appropriately set according to a known method.
[0079] 上述の PIフィルム等の接着性含フッ素高分子フィルム以外のフィルムと上述の接着 性フッ素榭脂との積層は、熱圧着にて行う場合、一般に、公知の押出成形法等にて 接着性フッ素榭脂をフィルムに成形したのち、得られた接着性フッ素榭脂フィルムと P Iフィルム等の接着性含フッ素高分子フィルム以外のフィルムとを重ね合わせて加熱 しながら圧着させること〖こより行うことができる。 [0079] When a film other than the above-mentioned adhesive fluorine-containing polymer film such as the above-mentioned PI film and the above-mentioned adhesive fluorine resin are laminated by thermocompression bonding, it is generally adhered by a known extrusion method or the like. After forming the fluorinated fluoro resin into a film, the obtained adhesive fluorinated resin film and a film other than an adhesive fluorinated polymer film such as a PI film are overlaid and heated and pressure-bonded. Can do.
上記熱圧着は、 120〜300°Cの温度にて行うことが好ましい。該温度は、より好まし Vヽ下限が 140°Cであり、より好ま ヽ上限が 280°Cである。 The thermocompression bonding is preferably performed at a temperature of 120 to 300 ° C. The temperature is more preferably V lower limit of 140 ° C and more preferably upper limit of 280 ° C.
上記 PIフィルム等の接着性含フッ素高分子フィルム以外のフィルムは、熱圧着等によ り貼り合わせて積層する場合、積層前に予め予熱してもよいし、予備乾燥してもよい。 また、熱圧着等により各層を貼り合わせる場合、層間接着性を向上させるため、貼り 合わせた後に加熱を行 、エージングさせてもよ!、。 When the films other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film are laminated by thermocompression bonding or the like, they may be preheated prior to lamination or pre-dried. Also, when bonding each layer by thermocompression bonding, etc., in order to improve interlayer adhesion, it is possible to heat and age after bonding!
上記エージングの為の加熱は、 200〜280°Cにて行うこと力 S好ましい。 The heating for the aging is preferably performed at 200 to 280 ° C.
[0080] 上記積層フィルムは、ヒートシール法などにより容器または袋状に成形する。具体的 には、積層フィルム 2枚を接着性含フッ素高分子フィルム同士が接するように重ねあ わせ、ヒートシールを行う。容器の内容積は一般的に約 2〜200mlである力 これに 限定されるものではない。また、ヒートシールの幅は、積層フィルム間のシール強度の 観点から、約 2〜20mm、好ましくは約 5〜 15mmである力 これに限定されるもので はない。さらに、ヒートシール温度についても、積層フィルム間のシール強度の観点 から、約 180〜250°C、好ましくは約 200〜220°Cである。汎用のフッ素榭脂フィルム は、 180〜250°Cという低い温度ではシールすることができない。つまり、本発明にお ける接着性含フッ素高分子フィルムは、低温でのヒートシール性が良好であるために 、製造工程におけるコストも低い。 [0080] The laminated film is formed into a container or bag shape by a heat sealing method or the like. Specifically, two laminated films are stacked so that the adhesive fluorine-containing polymer films are in contact with each other, and heat sealing is performed. The inner volume of the container is generally about 2 to 200 ml, but is not limited to this. The width of the heat seal is not limited to this, which is about 2 to 20 mm, preferably about 5 to 15 mm, from the viewpoint of the sealing strength between the laminated films. Further, the heat seal temperature is about 180 to 250 ° C, preferably about 200 to 220 ° C, from the viewpoint of the sealing strength between the laminated films. General-purpose fluororesin films cannot be sealed at temperatures as low as 180-250 ° C. In other words, the present invention Since the adhesive fluorine-containing polymer film has good heat sealability at low temperatures, the cost in the production process is also low.
[0081] 本発明の凍結保存容器は、例えば赤血球、血小板、血漿等の血液成分や、骨髄液 、その他の体液、細胞浮遊液等の生体試料を収容した後、凍結保存容器の破損時 における内容物の保護、凍結保存容器内への液体窒素が混入を防止するために、 さらに包装してもよい。これらの包装体としては、パーフルォロエチレンプロペン共重 合体製の包装体などが一般的に使用されているが、これに限定されるものではない。 この時、凍結保存容器と包装体との間の空気を、例えば特開 2000— 185716号公 報に開示された補助具などを用いることにより、容易に脱気することができて好ましい 力 これに限定されるものではない。 [0081] The cryopreservation container of the present invention contains, for example, blood components such as red blood cells, platelets, and plasma, and biological samples such as bone marrow fluid, other body fluids, and cell suspensions, and the contents when the cryopreservation container is damaged. It may be further packaged to protect materials and prevent liquid nitrogen from entering the cryopreservation container. As these packages, packages made of perfluoroethylenepropene copolymer are generally used, but are not limited thereto. At this time, the air between the cryopreservation container and the package can be easily degassed by using, for example, an auxiliary tool disclosed in Japanese Patent Application Laid-Open No. 2000-185716. It is not limited.
[0082] 本発明の凍結保存容器は、上記積層フィルムをヒートシール法などにより容器または 袋状に成形することにより製造することができる。得られる凍結保存容器は、上記積 層フィルムとして、接着性含フッ素高分子フィルムが少なくとも片方の最外面に存在 する積層フィルムを用いた場合、該凍結保存容器の少なくとも片方の最外面に接着 性含フッ素高分子フィルムが存在する容器とすることができ、好ましくは、少なくとも容 器の内側である最外面に接着性含フッ素高分子フィルムが存在する容器とする。 [0082] The cryopreservation container of the present invention can be produced by forming the laminated film into a container or bag shape by a heat seal method or the like. When the obtained cryopreservation container uses a laminated film in which an adhesive fluoropolymer film is present on at least one outermost surface as the above-mentioned laminated film, the cryopreservation container contains adhesiveness on at least one outermost surface. The container can be a container having a fluoropolymer film, and is preferably a container having an adhesive fluorine-containing polymer film at least on the outermost surface inside the container.
[0083] 本発明の凍結保存容器は—80〜一 196°Cの極低温下でも十分耐えうるものである 力 赤血球、血小板、血漿等の血液成分や、骨髄液、その他の体液および細胞浮遊 液などを実際に保存する場合は、これらの組織を損傷させないために、徐々に冷却 することが好ましい。例えば、一度ディープフリーザー(凍結機)などで約— 80度まで 冷却した後、液体窒素内に移すことによって保存する方法などが挙げられる力 これ に限定されるものではない。保存している血液、細胞などを使用する際は、例えば 37 〜40°Cの温浴などの加温手段によって解凍することができる力 これに限定されるも のではない。 [0083] The cryopreservation container of the present invention is capable of withstanding even at extremely low temperatures of -80 to 196 ° C. Forces Blood components such as erythrocytes, platelets and plasma, bone marrow fluid, other body fluids and cell suspensions In the case of actual storage, it is preferable to cool gradually in order not to damage these tissues. For example, the power is not limited to this, for example, a method of once cooling it to about −80 degrees with a deep freezer or the like and then storing it in liquid nitrogen. When using stored blood, cells, etc., the force that can be thawed by a heating means such as a 37-40 ° C. warm bath is not limited thereto.
[0084] 生体試料を保存する際には、市販の保存液を適宜使用することができる。例えば、 細胞を保存する場合、その保存液として DMEM培地、 RPMY1640培地、 199培地 及びリン酸緩衝液などが挙げられる。好ましくは、約 0. 5〜2容量%のアルブミンを添 カロしてもよい。さらに好ましくは、凍害保護剤としてジメチルスルホキシド (DMSO)を 最終濃度約 5〜20容量%添加してもよい。また、臓器を保存する場合、ユーロコリン ズ液及び UW液などが挙げられる。好ましくは、凍害保護剤としてジメチルスルホキシ ド (DMSO)を最終濃度約 5〜20容量%添加してもよ ヽ。これらの保存液の選択及 び調製は当業者が適宜選択できるものであるため特に限定されるものではない。 [0084] When the biological sample is stored, a commercially available storage solution can be appropriately used. For example, when cells are stored, examples of the storage solution include DMEM medium, RPMY1640 medium, 199 medium, and phosphate buffer. Preferably, about 0.5 to 2% by volume of albumin may be added. More preferably, dimethyl sulfoxide (DMSO) is used as a freezing protection agent. A final concentration of about 5-20% by volume may be added. When organs are preserved, Eurocollins solution and UW solution can be used. Preferably, dimethyl sulfoxide (DMSO) may be added as a frost damage protective agent to a final concentration of about 5 to 20% by volume. The selection and preparation of these preservation solutions are not particularly limited because they can be appropriately selected by those skilled in the art.
[0085] 生体試料を収容ないし収納した本発明の凍結保存容器の凍結方法としては、生体 試料を収容ないし収納した該凍結保存容器を 0°C以下で凍結させる方法が挙げられ る。上記凍結方法としては、 80°C以下で凍結させる方法が好ましい。上記凍結方 法においては、生体試料を損傷させないために、該凍結保存容器を所望の温度まで 徐々に冷却して凍結させることが好ましい。このような凍結方法としては、該凍結保存 容器を一度ディープフリーザー (凍結機)などで約 80°Cまで冷却した後、液体窒素 に浸漬する方法などが挙げられる。上記凍結保存容器には、必要に応じ、上述の保 存液をも収納してよい。上記凍結保存容器は、上記方法により凍結したのち、通常、 引き続き凍結保存する。 [0085] Examples of the method for freezing the cryopreservation container of the present invention containing or storing a biological sample include a method of freezing the cryopreservation container containing or storing a biological sample at 0 ° C or lower. As the freezing method, a method of freezing at 80 ° C. or lower is preferable. In the freezing method, it is preferable that the cryopreservation container is gradually cooled to a desired temperature and frozen in order not to damage the biological sample. Examples of such a freezing method include a method in which the cryopreservation container is once cooled to about 80 ° C. with a deep freezer (freezer) and then immersed in liquid nitrogen. The cryopreservation container may contain the above-described storage solution as necessary. The above cryopreservation container is usually kept frozen after being frozen by the above method.
[0086] 本発明の凍結保存容器は、上述の構成よりなるので、液体窒素温度(一 196°C)のよ うな極低温下においても破損せず、封止部におけるシール性も低下しないので、各 種凍結保存時において、液体窒素等の冷媒が浸入することがなぐ内容物の汚染及 び流出を防ぐことができ、優れた保護性能を示す。 [0086] Since the cryopreservation container of the present invention has the above-described configuration, it does not break even at an extremely low temperature such as liquid nitrogen temperature (196 ° C), and the sealing performance at the sealed portion does not deteriorate. It can prevent the contamination and spillage of the contents that liquid refrigerant such as liquid nitrogen does not enter during freezing storage, and exhibits excellent protection performance.
上記凍結保存容器は、更に、用いる接着性フッ素榭脂の融点未満であれば、上記 極低温ほどの低温でな 、低温領域下にあっても耐性があり、非常に幅広!、温度範囲 に耐性を示すことができるので、該極低温下においた後に常温下におく等の温度の 急変に対しても、破損及び封止部におけるシール性の低下がな 、。 Furthermore, the cryopreservation container is resistant to temperatures as low as the above-mentioned cryogenic temperatures as long as it is less than the melting point of the adhesive fluorocoagulant used. Therefore, even when the temperature is changed to a room temperature after being placed at the cryogenic temperature, there is no breakage and deterioration of the sealing performance at the sealing portion.
[0087] 本発明の凍結保存容器が上記優れた効果を奏する機構としては、明確ではないが、 例えば、上述の接着性含フッ素榭脂と PIとを積層してなるものである場合、(1) PIは 液体窒素温度のような極低温下においても成形体の形状を維持し得る耐極低温性 を有する、(2) PIフィルムと接着性フッ素榭脂層との層間接着性に優れる、(3) PIフィ ルムと接着性フッ素榭脂層とは、接着剤を使用しなくても直接接着することができ、接 着剤を用いる際の問題、即ち、接着剤層が液体窒素温度のような極低温下で脆化し 破壊する問題、及び、接着剤からのアウトガスや溶出物による問題がない、及び、(4 ) PIフィルムと接着性フッ素榭脂層とを積層してなる積層フィルムは、接着性フッ素榭 脂層同士を熱融着等させることにより凍結保存容器を形成するが、該接着性フッ素 榭脂層同士の接着性に優れ、シール性に信頼性がある、という各特性が相乗的に奏 するものと考えられる。 [0087] The mechanism by which the cryopreservation container of the present invention exhibits the above-mentioned excellent effects is not clear. For example, when the above-mentioned adhesive fluorine-containing resin and PI are laminated, (1 ) PI has extremely low temperature resistance that can maintain the shape of the molded body even at extremely low temperatures such as liquid nitrogen temperature. (2) Excellent interlayer adhesion between PI film and adhesive fluororesin layer. ( 3) The PI film and the adhesive fluororesin layer can be directly bonded without using an adhesive, and there is a problem when using an adhesive, that is, the adhesive layer is at a liquid nitrogen temperature. There is no problem of embrittlement and destruction at extremely low temperatures, and no problems due to outgas and elution from the adhesive, and (4 ) A laminated film formed by laminating a PI film and an adhesive fluororesin layer forms a cryopreservation container by thermally fusing the adhesive fluororesin layers to each other. It is considered that the properties of being excellent in adhesion between each other and reliable in sealing properties are synergistically exhibited.
[0088] 本発明の凍結保存容器は、生体試料用凍結保存容器として好適に用い得るもので ある。 [0088] The cryopreservation container of the present invention can be suitably used as a cryopreservation container for biological samples.
上記凍結保存容器に保存しうる生体試料としては、例えば、ヒト由来の生体試料、ヒト 以外の動物又は植物由来の生体試料、ウィルス、微生物等の生体試料が挙げられ る。 Examples of biological samples that can be stored in the cryopreservation container include biological samples derived from humans, biological samples derived from animals or plants other than humans, and biological samples such as viruses and microorganisms.
[0089] 本発明の凍結保存容器は、例えば、血液成分、細胞、組織、臓器、ウィルス、細菌類 、精子、卵子、受精卵などの生体試料を密封することができる容器である。 [0089] The cryopreservation container of the present invention is a container that can seal biological samples such as blood components, cells, tissues, organs, viruses, bacteria, sperm, eggs, fertilized eggs, and the like.
[0090] 上記血液成分は、全血、赤血球、白血球、血漿、血小板および多血小板血漿などが 挙げられる。また、細胞としては、造血幹細胞、 ES細胞、間葉系幹細胞、骨骸単核 細胞、精子細胞および卵子細胞などの希少細胞の他、神経細胞、上皮細胞、繊維 芽細胞等の一般的な細胞等が挙げられる。さらに、生体組織としては、組織等として 、腱、神経、靱帯、食道、気管、脾島等の各種器官の他、粘膜上皮組織、角膜上皮 組織および培養角膜組織などの膜組織ならびに臓器としては、脾臓、心臓、肺、肝 臓および腎臓などが挙げられる。ウィルスとしては、 B型肝炎ウィルス、 C型肝炎ウイ ルス、コロナウィルス及びモザイクウィルス等が挙げられる。細菌類しては、結核菌、 インフルエンザ菌、大腸菌、黄色ブドウ球菌、溶血れんさ球菌及び肺炎桿菌等が挙 げられる。また、精子、卵子及び受精卵が、例えば、不妊治療分野等に関して挙げら れる。これらの保存する血液ないし血液成分、稀少細胞を含む細胞その他の生体組 織は、作業者の目的に応じて選択されるものであり、特に限定されるものではない。 [0090] Examples of the blood components include whole blood, red blood cells, white blood cells, plasma, platelets, and platelet-rich plasma. The cells include hematopoietic stem cells, ES cells, mesenchymal stem cells, skeletal mononuclear cells, rare cells such as sperm cells and egg cells, and general cells such as nerve cells, epithelial cells, fibroblasts, etc. Is mentioned. Furthermore, as a biological tissue, as various tissues such as tendons, nerves, ligaments, esophagus, trachea, and spleen, as well as membrane tissues and organs such as mucosal epithelial tissue, corneal epithelial tissue and cultured corneal tissue, Examples include the spleen, heart, lungs, liver and kidneys. Examples of viruses include hepatitis B virus, hepatitis C virus, coronavirus, and mosaic virus. Examples of the bacteria include tuberculosis bacteria, Haemophilus influenzae, Escherichia coli, Staphylococcus aureus, hemolyzed staphylococci, and Klebsiella pneumoniae. In addition, sperm, ovum and fertilized egg are mentioned in the field of infertility treatment, for example. These stored blood or blood components, cells containing rare cells, and other biological tissues are selected according to the purpose of the operator and are not particularly limited.
[0091] 上記生体組織としては、また、例えば、生体の体液 (血液、髄液、リンパ液等)及びそ の成分 (赤血球、白血球、血小板、血漿、血清等)、生体内組織 (血管、角膜、半月 板、脳組織、皮膚、皮下組織、上皮組織、骨組織、筋組織等)、臓器 (眼、肺、腎臓、 心臓、肝臓、脾臓、脾臓、消化管、膀胱、卵巣及び精巣等)、各種細胞 (臍帯血,末 梢血由来造血幹細胞等の造血幹細胞、骨髄細胞、肝細胞、脾細胞及び脳細胞等の 各種臓器細胞、神経細胞、精子、卵細胞、受精卵、胚性幹細胞 (ES細胞)、研究,治 療用癌細胞、培養細胞、幹細胞、胚細胞等)等が挙げられる。 [0091] Examples of the biological tissue include biological fluids (blood, cerebrospinal fluid, lymph, etc.) and components thereof (red blood cells, white blood cells, platelets, plasma, serum, etc.), and biological tissues (blood vessels, cornea, Meniscus, brain tissue, skin, subcutaneous tissue, epithelial tissue, bone tissue, muscle tissue, etc.), organs (eye, lung, kidney, heart, liver, spleen, spleen, digestive tract, bladder, ovary, testis, etc.), various Cells (such as cord blood, hematopoietic stem cells such as peripheral blood-derived hematopoietic stem cells, bone marrow cells, hepatocytes, spleen cells and brain cells) Various organ cells, nerve cells, sperm, egg cells, fertilized eggs, embryonic stem cells (ES cells), cancer cells for research and treatment, cultured cells, stem cells, embryo cells, etc.).
[0092] 上記生体試料としては、ヒトの生体組織、遺伝関連物質等の他、実験用小動物等の 小動物を含む動物の生体組織及び遺伝関連物質;微生物、細菌類、及び、これらの 遺伝関連物質;等が挙げられ、これらは、例えば、研究分野において用いられるもの 等が挙げられる。 [0092] Examples of the biological sample include human biological tissues and genetic related substances, as well as biological tissues and genetic related substances of animals including small animals such as small experimental animals; microorganisms, bacteria, and genetic related substances thereof. These include, for example, those used in the research field.
[0093] 上記生体試料としては、また、家畜 ·動物の生体組織及び遺伝関連物質が挙げられ 、これらは、例えば、研究、培養、栽培、園芸等の農業分野において用いられるもの 等が挙げられる。 [0093] Examples of the biological sample also include livestock / animal biological tissues and genetic materials, and examples thereof include those used in the agricultural field such as research, culture, cultivation, and horticulture.
上記生体試料としては、また、植物の種子、花粉、培養細胞、茎頂細胞及び遺伝関 連物質が挙げられる。 Examples of the biological sample also include plant seeds, pollen, cultured cells, shoot apical cells, and genetic materials.
上記生体試料としては、また、海洋性藻類、魚類等の生体組織及び遺伝関連物質 等が挙げられ、これらは、例えば、研究等の水産分野において用いられるもの等が挙 げられる。 Examples of the biological sample also include biological tissues such as marine algae and fish and genetic related substances, and examples thereof include those used in the field of fisheries such as research.
上述の遺伝子関連物質としては、 DNA、宿主、ベクター等が挙げられる。 Examples of the above-mentioned gene-related substances include DNA, host, vector and the like.
[0094] 上記生体試料は、例えば、医療用;農蓄産業、林業、水産業、園芸等の分野におけ る研究'開発用;ペット産業、動物産業における動物の治療用、不妊治療等の繁殖 関連用、クローン技術用等として、使用することができる。 [0094] The biological sample is, for example, for medical use; for research and development in the fields of agriculture, forestry, fisheries, horticulture, etc .; for animal treatment, fertility treatment, etc. in the pet industry and animal industry. It can be used for related purposes, cloning techniques, etc.
[0095] このように、本発明の凍結保存容器は、医療;研究;畜産、園芸等の農業;水産等の 各種分野において使用することができる。 As described above, the cryopreservation container of the present invention can be used in various fields such as medicine; research; agriculture such as livestock and horticulture;
実施例 Example
[0096] 以下に本発明を、実施例を用いて詳細に説明するが、本発明はこれらの実施例に限 定されるものではない。 [0096] Hereinafter, the present invention will be described in detail using examples, but the present invention is not limited to these examples.
[0097] 実施例 1〜8:凍結保存容器の製造 [0097] Examples 1-8: Production of cryopreservation containers
ポリイミドフィルムの片面または両面に、ポリテトラフルォロエチレンと、パーフルォロ( ビュルプロピルエーテル)と、パーフルオロー(1, 1, 9, 9ーテトラハイドロー 2, 5 ビ ストリフルォロメチルー 3, 6 ジォキサ 8—ノネノール)との 3成分系ランダム共重合 体フィルム(以下、それぞれ内層フッ素榭脂フィルム、外層フッ素榭脂フィルムとする) を重ねあわせ、熱ラミネート法により 2層および 3層フィルムを作製した。上記フィルム を寸法 180 X 100mmになるようにカットしたシートを、内層フッ素榭脂フィルムが接 するように 2枚重ね合わせてヒートシール法により縁部 10mmを熱溶着させることによ り凍結保存容器を作成した。各フィルム層の膜厚を表 1に示す。 Polytetrafluoroethylene, perfluoro (bulpropyl ether), perfluoro (1, 1, 9, 9-tetrahydro-2, 5-bistrifluoromethyl-3, 6 dioxaxene on one or both sides of the polyimide film 8-component random copolymer film (hereinafter referred to as inner layer fluororesin film and outer layer fluororesin film, respectively) Two-layer and three-layer films were prepared by the heat laminating method. Two sheets of the above film cut to a size of 180 x 100 mm are stacked so that the inner fluororesin film is in contact with each other, and the edge 10 mm is heat-sealed by the heat seal method to form a cryopreservation container. Created. Table 1 shows the film thickness of each film layer.
上記 3成分系ランダム共重合体フィルムの共重合組成比は、パーフルオロー(1, 1, 9, 9—テトラハイド口一 2, 5—ビストリフルォロメチル一 3, 6—ジォキサ一 8—ノネノー ル)モノマーユニット 1に対して、ポリテトラフルォロエチレンモノマーユニットと、パー フルォロ(ビュルプロピルエーテル)モノマーユニットとの合計が 99であった。上記共 重合組成比は、 19F— NMRにより測定した。 The copolymer composition ratio of the above three-component random copolymer film is as follows: perfluoro (1, 1, 9, 9—tetrahydride 1, 2, 5-bistrifluoromethyl 1, 3, 6—dioxa 8—nonenor ) For monomer unit 1, the total number of polytetrafluoroethylene monomer units and perfluoro (bulupropyl ether) monomer units was 99. The copolymer composition ratio was measured by 19 F-NMR.
[0098] 比較例 1 :比較の凍結保存容器 1 [0098] Comparative Example 1: Comparative cryopreservation container 1
市販されて ヽるエチレン—酢酸ビニル共重合体製の凍結保存容器 (BAXER社製) を用いた。 A commercially available cryopreservation container (manufactured by BAXER) made of an ethylene-vinyl acetate copolymer was used.
[0099] 比較例 2 :比較の凍結保存容器 2 [0099] Comparative Example 2: Comparative cryopreservation container 2
市販されて 、るポリエチレン製の凍結保存容器 (CharterMed社製)を用いた。 A commercially available cryopreservation container made of polyethylene (CharterMed) was used.
[0100] 合成例 1 (接着性フッ素榭脂の合成) [0100] Synthesis Example 1 (Synthesis of adhesive fluorine resin)
内容積 820Lのガラスライニング性オートクレープに純水 200Lを入れ、径内を窒素 ガスで充分に置換した後、真空にし、 1—フルォロ— 1, 1—ジクロロェタン 113kg及 びへキサフルォロプロピレン 95kg、シクロへキサン 85gを仕込んだ。次いで、パーフ ルォロ(1, 1, 5—トリハイド口— 1—ペンテン) [CH =CF (CF ) H] 292gを窒素ガ 200L of pure water is placed in a glass-lined autoclave with an internal volume of 820L, the inside of the diameter is sufficiently replaced with nitrogen gas, and then vacuumed to give 113kg of 1-fluoro-1,1-dichloroethane and 95kg of hexafluoropropylene. , 85 g of cyclohexane was charged. Next, perfluoro (1, 1, 5—trihydre port—1—pentene) [CH = CF (CF) H]
2 2 3 2 2 3
スを用いて圧入し、槽内温度を 35°C、攪拌速度を 200rpmに保った。更にテトラフル ォロエチレンを 7. 25kgZcm2Gになるまで圧入し、その後、エチレンを 8kgZcm2G になるまで圧入した。 The inside temperature was kept at 35 ° C and the stirring speed was kept at 200 rpm. Further, tetrafluoroethylene was injected into 7.25 kgZcm 2 G, and then ethylene was injected into 8 kgZcm 2 G.
[0101] 次いで、ジー n—プロピルパーォキシジカーボネートの 50質量0 /0メタノール溶液 1. 9 kgを仕込むことにより、重合を開始した。重合の進行と共に槽内圧力が低下するので[0101] Then, by charged with 50 mass 0/0 methanol solution 1. 9 kg of di-n- propyl Per O carboxymethyl dicarbonate, to initiate polymerization. Since the pressure in the tank decreases as the polymerization progresses
、テトラフルォロエチレン Zエチレン Zへキサフルォロプロピレンの混合ガス(モル比, Tetrafluoroethylene Z ethylene Z hexafluoropropylene mixed gas (molar ratio)
= 39. 2 :43. 6 : 17. 3)を追加圧入して、重合圧力を 8kgZcm¾に保ちながら重合 を続け、途中、 CH =CF (CF ) HI lOOgを 20回に分割してマイクロポンプで仕込 = 39.2: 43.6: 17.3), and the polymerization was continued while maintaining the polymerization pressure at 8 kgZcm¾, and CH = CF (CF) HI lOOg was divided into 20 times during the process. Preparation
2 2 3 2 2 3
み、重合を合計 32時間行った。重合終了後、内容物を回収し、水洗し、粉末状の接 着性フッ素榭脂を 95kg得た。 The polymerization was conducted for a total of 32 hours. After polymerization is complete, the contents are recovered, washed with water, and contacted with powder. 95 kg of adhesive fluorocoagulant was obtained.
[0102] 得られた接着性フッ素榭脂について、以下の測定を行った。 [0102] The following measurement was performed on the obtained adhesive fluorocoating.
( 1)モノマー単位 (1) Monomer unit
19F— NMR分析を行い、測定した。 19 F—NMR analysis was performed and measured.
(2)カーボネート基数 (2) Number of carbonate groups
接着性フッ素榭脂の粉末を室温にて圧縮成形し、厚さ 0. 05-0. 2mmフィルムを作 製した。得られたフィルムについて赤外吸収スペクトル分析を行い、カーボネート基 [ OC ( = O)— O ]中のカルボ-ル基が帰属するピーク [ 1809cm_ 1 ( v ;) ]の c=o 吸光度を測定した。得られた測定値から、下記式に基づき主鎖炭素数 I X 106個あ たりのカーボネート基の個数を算出した。 Adhesive fluorocobalt powder was compression molded at room temperature to produce a 0.05-0. Infrared absorption spectrum analysis was performed on the resulting film, and the c = o absorbance of the peak [1809cm _ 1 (v;)] attributed to the carbo group in the carbonate group [OC (= O) -O] was measured. did. From the measured values obtained, the number of carbonate groups per IX 10 6 main chain carbon atoms was calculated based on the following formula.
N= 500AW/ ε df N = 500AW / ε df
A :上記 v の吸光度 A: Absorbance of v above
ε:上記 ν ε: ν above
(モデル化合物より ε = 170とした。) (From the model compound, ε = 170)
W:モノマー組成から計算される組成平均分子量 W: Composition average molecular weight calculated from the monomer composition
d :フィルムの密度 [g/cm3] d: Density of film [g / cm 3 ]
f:フィルムの厚さ [mm]マイクロメーターにて測定。 f: Film thickness [mm] Measured with a micrometer.
上記赤外吸収スぺクトノレ分析は、 Perkin— Elmer FTIRスぺクトロメーター 1760X The infrared absorption spectrum analysis described above is based on the Perkin—Elmer FTIR Spectrometer 1760X
(Perkin— Elmer社製)を用いて 40回スキャンして行った。 v の吸光度の解析は c=o Scanning was performed 40 times using (Perkin—Elmer). The absorbance analysis of v is c = o
、 Perkin— Elmer Spectrum for Windows (登録商標) Ver. 1. 4Cソフトゥェ ァにて行った。 Perkin—Elmer Spectrum for Windows (registered trademark) Ver. 1. 4C software.
(3)融点 (3) Melting point
示差走査熱量計 (セイコー社製)を用い、昇温速度 10°CZ分にて測定し、得られた 融解ピークの極大値での温度を融点とした。 Using a differential scanning calorimeter (manufactured by Seiko Co., Ltd.), the temperature was measured at a rate of temperature increase of 10 ° CZ, and the temperature at the maximum value of the melting peak obtained was taken as the melting point.
[0103] 得られた接着性フッ素榭脂は、モノマー単位が TFEZEtZHFPZ [CH = CF (CF [0103] The obtained adhesive fluorine resin has a monomer unit of TFEZEtZHFPZ [CH = CF (CF
2 2
) H] = 38. 9/45. 9/14. 8/0. 4であり、カーボネート基数が主鎖炭素数 1 X 1 H] = 38. 9/45. 9/14. 8/0. 4 and the number of carbonate groups is 1 X 1
2 3 twenty three
06個あたり 411個であり、融点が 171. 8°Cであった。 0 The number was 411 per 6 and the melting point was 171.8 ° C.
[0104] 実施例 9 (1)合成例から得られた接着性フッ素榭脂にっ ヽて、シリンダ直径 90mmの単軸押 出し機に Tダイを接続し、シリンダ温度 170〜230°C、ダイ温度 230°C、スクリュー回 転数 lOrpmの条件下にて、接着性フッ素榭脂フィルム (厚み: 25 m)を成形した。 得られた接着性フッ素榭脂フィルムと、ポリイミドフィルム (製品名:カプトン 100H、東 レ.デュポン社製、厚み: 25 μ m)とを、温度 250°Cの条件下にて熱ロールでラミネー トして、積層フィルム(長さ 20m X幅 200mm X全体厚み 50 πι。以下、長尺フィル ムとも 、う。)を得た。得られた積層フィルム (フッ素榭脂層の厚さ; 25 m、ポリイミド 層の厚さ;25 /z m)の接着強度について、長さ方向に 100mm、幅方向に 10mmの 短冊状に切り出し、その端のフッ素榭脂層とポリイミド層とを刃物を用いて剥離し掴み しろを作り、テンシロン万能試験機 (オリエンテック社製)を用いて 25mmZ分の速度 で 180° 剥離させて測定したところ、 400NZmであった。 [0104] Example 9 (1) A T-die is connected to a single-screw extruder with a cylinder diameter of 90 mm using the adhesive fluorine resin obtained from the synthesis example, the cylinder temperature is 170 to 230 ° C, the die temperature is 230 ° C, the screw An adhesive fluororesin film (thickness: 25 m) was molded under the condition of the number of revolutions lOrpm. The adhesive fluororesin film obtained and a polyimide film (product name: Kapton 100H, manufactured by Toray DuPont, thickness: 25 μm) are laminated with a hot roll at a temperature of 250 ° C. Thus, a laminated film (length 20 m × width 200 mm × total thickness 50 πι, hereinafter referred to as a long film) was obtained. The resulting laminated film (fluorine-resin layer thickness: 25 m, polyimide layer thickness: 25 / zm) was cut into a strip of 100 mm in the length direction and 10 mm in the width direction, and its edges Fluorine resin layer and polyimide layer were peeled off using a blade to make a margin, and measured using a Tensilon universal testing machine (Orientec Co., Ltd.) 180 ° peeled at a rate of 25 mmZ, measured at 400 NZm. there were.
(2)続いて、上記長尺フィルムから 12cm角に切り出した積層フィルム 2枚を、シール 幅 (貼付しろ) 1cmとして接着性フッ素榭脂層を内側にして重ね、 3辺をヒートシーラ 一で 210°C X 5秒の条件で熱融着した。更に、 1辺の開口部から lOOmL純水を投入 して、空気が入らないように該開口部をヒートシールして、縦 10cm X横 10cm X高さ lcmの上記純水により満たされた内部空間を持つ袋を作成した。 (2) Next, two laminated films cut into 12cm squares from the above long film were stacked with a seal width of 1cm with the adhesive fluorocoagulant layer inside, and the 3 sides were 210 ° in one heat sealer. CX was heat-sealed for 5 seconds. Furthermore, lOOmL pure water is introduced from one side of the opening, and the opening is heat-sealed so that air does not enter, and the internal space filled with the above-mentioned pure water 10 cm long × 10 cm wide × lcm high Created a bag with.
本方法にて 10個の袋を作成し、これらを— 196°Cの液体窒素中に 24時間浸漬した のち、 37°Cの温水中にて解凍したところ、 10個とも袋の破裂、内容物の漏れ等がな かった。 Ten bags were made by this method, and these were immersed in 196 ° C liquid nitrogen for 24 hours and then thawed in 37 ° C warm water. There was no leakage.
以上より、本発明の凍結保存容器は、液体窒素浸漬に充分対応可能と考えられた。From the above, it was considered that the cryopreservation container of the present invention can sufficiently cope with liquid nitrogen immersion.
(3)上記長尺フィルムから 12cm角に切り出した積層フィルム 2枚を、シール幅 (貼付 しろ) lcmとして接着性フッ素榭脂層を内側にして重ね、 3辺をヒートシ一ラーで 210 °C X 5秒の条件で熱融着し、容量 25mlの凍結保存容器を作成した。ポリイミドフィル ムと、接着性フッ素榭脂フィルム(内層フッ素榭脂フィルム)の膜厚を表 1に示す。 実験例 1 :凍結試験 (3) Laminate two sheets of 12cm square cut from the above long film with a seal width (paste) of lcm, with the adhesive fluororesin layer inside, and 3 sides with heat sealer at 210 ° CX 5 A 25-ml cryopreservation container was prepared by heat-sealing under the conditions of seconds. Table 1 shows the film thicknesses of the polyimide film and adhesive fluorine resin film (inner layer fluorine resin film). Experimental example 1: Freezing test
実施例 1〜9で作製された凍結保存容器および比較例 1、 2の凍結保存容器それぞ れにジメチルスルホキシド(DMSO) 10% (vZv)水溶液 80mlを充填し、十分に空気 を抜いた後、アルミ製のケースに収納した。アルミ製ケースに収納した容器をディー プフリーザー(凍結機)にて— 80°C、 4時間静置し、凍結させた。次にこの凍結した容 器を液体窒素内に移し、 1週間保存した。保存した容器を、アルミケース力も取り出し 、 37〜40°Cの温浴中で容器を解凍し、容器に破損、液体窒素の混入などが起きて な!、かどうかを目視観察した。 The cryopreservation containers prepared in Examples 1 to 9 and the cryopreservation containers of Comparative Examples 1 and 2 were each filled with 80 ml of a dimethyl sulfoxide (DMSO) 10% (vZv) aqueous solution, and the air was sufficiently evacuated. Housed in an aluminum case. Dee container stored in aluminum case It was left to stand at 80 ° C for 4 hours in a freezer (freezer) and frozen. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and the container was visually inspected for damage and liquid nitrogen contamination.
[0106] その実験の結果を表 2に示す。比較例 1は 20%、比較例 2は 10%破損したのに対し て、本発明の凍結保存容器は、 30個という膨大な試験数をこなしたにも関わらず、 つも破損が見られな力つた。 [0106] Table 2 shows the results of the experiment. While Comparative Example 1 was damaged by 20% and Comparative Example 2 was broken by 10%, the cryopreservation container of the present invention had a huge number of tests of 30 pieces, but it was not damaged. I got it.
[0107] [表 1] [0107] [Table 1]
[0108] [表 2] [0108] [Table 2]
[0109] 実験例 2 :凍結試験 [0109] Experimental Example 2: Freezing test
細胞懸濁液は、 RPMI1640培地(Invitorogen株式会社製)に MOLT— 4細胞(理 研株式会社から譲渡)を約 1. 0 X 107 cells/mlの濃度で調製した。実施例 9で作製 された凍結保存用容器および比較例 1の凍結保存容器それぞれにジメチルスルホキ シド (DMSO) 10% (v/v)の細胞懸濁液 80mlを充填し、十分に空気を抜いた後、 アルミ製のケースに収納した。アルミ製ケースに収納した容器をディープフリーザー( 凍結機)にて— 80°C、 4時間静置し、凍結させた。次にこの凍結した容器を液体窒素 内に移し、 1週間保存した。保存した容器を、アルミケース力も取り出し、 37〜40°C の温浴中で容器を解凍し、容器に破損、液体窒素の混入などが起きてないかどうか を目視観察した。試験はそれぞれ 5回ずつ行った。 Cell suspensions were prepared at a concentration of MOLT- 4 cells RPMI1640 medium (manufactured by Invitorogen Co., Ltd.) (the transfer from RIKEN Corporation) about 1. 0 X 10 7 ce lls / ml. Made in Example 9 Each of the cryopreservation container and the cryopreservation container of Comparative Example 1 were filled with 80 ml of a cell suspension of dimethylsulfoxide (DMSO) 10% (v / v), fully evacuated, and then made of aluminum. Stored in a case. The container housed in the aluminum case was frozen at 80 ° C for 4 hours using a deep freezer. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and visually inspected the container for damage and liquid nitrogen contamination. Each test was conducted 5 times.
[0110] その結果、比較例 1の凍結保存容器は 1個破損したのに対して、本発明の凍結保存 用容器は 5個とも破損が見られなカゝつた。 As a result, one of the cryopreservation containers of Comparative Example 1 was damaged, while all five of the cryopreservation containers of the present invention were not damaged.
産業上の利用可能性 Industrial applicability
[0111] 本発明の凍結保存容器は、極低温環境下で血液、稀少細胞および生体組織を保存 する際に、破損することなく保存することを可能にする。また、膜厚が比較的薄いため に凍結保存容器の内容物への熱伝導度を低減させることがない。さらに凍結保存容 器を収容した後のヒートシールによる密封性が非常によいために、内部への液体窒 素の混入を防止することができ、液体窒素内の細菌またはウィルスなどによる汚染お よび解凍時における混入した液体窒素の膨張による凍結保存容器の破裂を防止す ることがでさる。 [0111] The cryopreservation container of the present invention makes it possible to store blood, rare cells, and biological tissues without damage in a cryogenic environment. In addition, since the film thickness is relatively thin, the thermal conductivity to the contents of the cryopreservation container is not reduced. Furthermore, since the sealability by heat sealing after storing the cryopreservation container is very good, it is possible to prevent the inside of the liquid nitrogen from being mixed, and contamination and thawing by bacteria or viruses in the liquid nitrogen. It is possible to prevent the cryopreservation container from rupturing due to the expansion of mixed liquid nitrogen.
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007509372A JP5090902B2 (en) | 2005-03-25 | 2006-03-27 | Cryopreservation container and manufacturing method thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-090010 | 2005-03-25 | ||
JP2005090010 | 2005-03-25 | ||
JP2005-128458 | 2005-04-26 | ||
JP2005128458 | 2005-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006101237A1 true WO2006101237A1 (en) | 2006-09-28 |
Family
ID=37023883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/306183 WO2006101237A1 (en) | 2005-03-25 | 2006-03-27 | Freeze storage container and process for producing the same |
Country Status (3)
Country | Link |
---|---|
JP (2) | JP5090902B2 (en) |
TW (1) | TW200708305A (en) |
WO (1) | WO2006101237A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015133480A (en) * | 2013-12-10 | 2015-07-23 | 旭硝子株式会社 | Adhesive film for coverlay, coverlay, wiring board and method of manufacturing electronic apparatus |
WO2017061097A1 (en) * | 2015-10-05 | 2017-04-13 | 山下 直樹 | Culturing-container display sticker |
JPWO2016088723A1 (en) * | 2014-12-02 | 2017-09-14 | 株式会社北里バイオファルマ | Collected biological tissue cryopreservation tool and collected tissue piece freezing method |
US12239127B2 (en) | 2021-07-28 | 2025-03-04 | Sartorius Stedim North America Inc. | Thermal capacitors, systems, and methods for rapid freezing or heating of biological materials |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102311221B1 (en) * | 2014-04-28 | 2021-10-13 | 삼성전자주식회사 | operating method and electronic device for object |
JP2018011809A (en) * | 2016-07-22 | 2018-01-25 | 大日本印刷株式会社 | Cell cryopreservation container |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54144275A (en) * | 1978-04-28 | 1979-11-10 | Toppan Printing Co Ltd | Container resistant to heat and very low temperature |
JPS5967960A (en) * | 1982-10-09 | 1984-04-17 | テルモ株式会社 | Blood preserving container |
JPH06263951A (en) * | 1993-03-16 | 1994-09-20 | Asahi Glass Co Ltd | Curable fluororubber composition |
JPH06271733A (en) * | 1993-03-17 | 1994-09-27 | Asahi Glass Co Ltd | Vulcanizable fluororubber composition |
WO1998046426A1 (en) * | 1997-04-15 | 1998-10-22 | Daikin Industries, Ltd. | Chemical-resistant composite material |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE340144B (en) * | 1967-02-01 | 1971-11-08 | Investrop Ag | |
US5250044A (en) * | 1990-02-06 | 1993-10-05 | Du Pont Merck Pharmaceutical Company | Blood cryopreservation container |
EP1160270A4 (en) * | 1998-10-06 | 2003-03-19 | Daikin Ind Ltd | NON-PERFLUORINATED FLUORINATED RESIN MOLDED ARTICLE WITH LOW TEMPERATURE THERMOSCELLABILITY |
JPWO2004018201A1 (en) * | 2002-08-21 | 2005-12-08 | ダイキン工業株式会社 | Fluorine-containing laminate and method for producing fluorine-containing laminate |
-
2006
- 2006-03-24 TW TW095110641A patent/TW200708305A/en unknown
- 2006-03-27 JP JP2007509372A patent/JP5090902B2/en active Active
- 2006-03-27 WO PCT/JP2006/306183 patent/WO2006101237A1/en active Application Filing
-
2012
- 2012-06-06 JP JP2012129301A patent/JP5548732B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54144275A (en) * | 1978-04-28 | 1979-11-10 | Toppan Printing Co Ltd | Container resistant to heat and very low temperature |
JPS5967960A (en) * | 1982-10-09 | 1984-04-17 | テルモ株式会社 | Blood preserving container |
JPH06263951A (en) * | 1993-03-16 | 1994-09-20 | Asahi Glass Co Ltd | Curable fluororubber composition |
JPH06271733A (en) * | 1993-03-17 | 1994-09-27 | Asahi Glass Co Ltd | Vulcanizable fluororubber composition |
WO1998046426A1 (en) * | 1997-04-15 | 1998-10-22 | Daikin Industries, Ltd. | Chemical-resistant composite material |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015133480A (en) * | 2013-12-10 | 2015-07-23 | 旭硝子株式会社 | Adhesive film for coverlay, coverlay, wiring board and method of manufacturing electronic apparatus |
JPWO2016088723A1 (en) * | 2014-12-02 | 2017-09-14 | 株式会社北里バイオファルマ | Collected biological tissue cryopreservation tool and collected tissue piece freezing method |
WO2017061097A1 (en) * | 2015-10-05 | 2017-04-13 | 山下 直樹 | Culturing-container display sticker |
US12239127B2 (en) | 2021-07-28 | 2025-03-04 | Sartorius Stedim North America Inc. | Thermal capacitors, systems, and methods for rapid freezing or heating of biological materials |
Also Published As
Publication number | Publication date |
---|---|
JP5548732B2 (en) | 2014-07-16 |
TW200708305A (en) | 2007-03-01 |
JP5090902B2 (en) | 2012-12-05 |
JP2012236035A (en) | 2012-12-06 |
JPWO2006101237A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5090903B2 (en) | Cryopreservation container package and manufacturing method thereof | |
JP5548732B2 (en) | Cryopreservation container and manufacturing method thereof | |
JP4016044B2 (en) | Retortable multilayer barrier film without halogen | |
EP0098312B1 (en) | A container resistant to extremely low temperatures | |
US5998019A (en) | Multi-layered polymer structure for medical products | |
IE53282B1 (en) | Platelet storage container | |
JP2008195443A (en) | Frozen storage container | |
JP2007161307A (en) | Refrigerating receptacle, its manufacturing method and refrigerating method of living specimen | |
US6071690A (en) | Ionomeric modified poly-ether-ester plastic container for cryogenic fluids | |
JP5028853B2 (en) | Bag for heat treatment | |
JP5109631B2 (en) | Cryopreservation bag and cryopreservation method | |
US20050129887A1 (en) | Medical freezer bag | |
JPH111247A (en) | Bag for freeze preservation | |
JP3941091B2 (en) | Cryopreservation method | |
JPS6136941B2 (en) | ||
JPS6159738B2 (en) | ||
AU2010201489B2 (en) | High abuse heat shrinkable film | |
US10486403B2 (en) | Ovenable thermoformable film | |
JPH0613714Y2 (en) | Frozen baguette | |
JP2024002939A (en) | Sealant film for cell culture vessels | |
EP2737999A1 (en) | High abuse heat shrinkable film | |
JPS6339258B2 (en) | ||
JPS6254730A (en) | Packaging material | |
JPH03295557A (en) | Refrigerating bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007509372 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06730131 Country of ref document: EP Kind code of ref document: A1 |